{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:42:44Z","timestamp":1787024564592,"version":"build-2736575974"},"reference-count":306,"publisher":"Bentham Science Publishers Ltd.","issue":"30","funder":[{"DOI":"10.13039\/501100004386","name":"University of Malaya Postgraduate Research","doi-asserted-by":"publisher","award":["PG046-2016A"],"award-info":[{"award-number":["PG046-2016A"]}],"id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004386","name":"University of Malaya Research","doi-asserted-by":"publisher","award":["UMRGRP027A-15AFR"],"award-info":[{"award-number":["UMRGRP027A-15AFR"]}],"id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,9,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>To date, there is still no approved anti-dengue agent to treat dengue infection in the market.\nAlthough the only licensed dengue vaccine, Dengvaxia is available, its protective efficacy\nagainst serotypes 1 and 2 of dengue virus was reported to be lower than serotypes 3 and 4. Moreover,\naccording to WHO, the risk of being hospitalized and having severe dengue increased in seronegative\nindividuals after they received Dengvaxia vaccination. Nevertheless, various studies had\nbeen carried out in search of dengue virus inhibitors. These studies focused on the structural (C,\nprM, E) and non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) of dengue\nvirus as well as host factors as drug targets. Hence, this article provides an overall up-to-date review\nof the discovery of dengue virus inhibitors that are only targeting the structural and non-structural\nviral proteins as drug targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867326666181204155336","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T07:09:55Z","timestamp":1543907395000},"page":"4945-5036","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Discovery of Dengue Virus Inhibitors"],"prefix":"10.2174","volume":"27","author":[{"given":"Adib Afandi","family":"Abdullah","sequence":"first","affiliation":[{"name":"Drug Design and Development Research Group (DDDRG), University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yean Kee","family":"Lee","sequence":"additional","affiliation":[{"name":"Drug Design and Development Research Group (DDDRG), University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sek Peng","family":"Chin","sequence":"additional","affiliation":[{"name":"Drug Design and Development Research Group (DDDRG), University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"See Khai","family":"Lim","sequence":"additional","affiliation":[{"name":"Drug Design and Development Research Group (DDDRG), University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vannajan Sanghiran","family":"Lee","sequence":"additional","affiliation":[{"name":"Drug Design and Development Research Group (DDDRG), University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozana","family":"Othman","sequence":"additional","affiliation":[{"name":"Drug Design and Development Research Group (DDDRG), University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatrah","family":"Othman","sequence":"additional","affiliation":[{"name":"Drug Design and Development Research Group (DDDRG), University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorsaadah Abdul","family":"Rahman","sequence":"additional","affiliation":[{"name":"Drug Design and Development Research Group (DDDRG), University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohana","family":"Yusof","sequence":"additional","affiliation":[{"name":"Drug Design and Development Research Group (DDDRG), University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon Han","family":"Heh","sequence":"additional","affiliation":[{"name":"Drug Design and Development Research Group (DDDRG), University of Malaya, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4269\/ajtmh.2011.10-0503","volume":"84","author":"Shepard D.S.","year":"2011","unstructured":"Shepard D.S.; Coudeville L.; Halasa Y.A.; Zambrano B.; Dayan G.H.; Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 2011,84(2),200-207","journal-title":"Am J Trop Med Hyg"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002055","volume":"7","author":"Shepard D.S.","year":"2013","unstructured":"Shepard D.S.; Undurraga E.A.; Halasa Y.A.; Economic and disease burden of dengue in Southeast Asia. PLoS Negl Trop Dis 2013,7(2)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=3","year":"2009","unstructured":"World Health Organization Dengue: guidelines for diagnosis, treatment, prevention and control: new edition 2009","journal-title":"World Health Organization Dengue: guidelines for diagnosis, treatment, prevention and control: new edition"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"Bhatt S.","year":"2013","unstructured":"Bhatt S.; Gething P.W.; Brady O.J.; Messina J.P.; Farlow A.W.; Moyes C.L.; Drake J.M.; Brownstein J.S.; Hoen A.G.; Sankoh O.; Myers M.F.; George D.B.; Jaenisch T.; Wint G.R.; Simmons C.P.; Scott T.W.; Farrar J.J.; Hay S.I.; The global distribution and burden of dengue. Nature 2013,496(7446),504-507","journal-title":"Nature"},{"key":"ref=5","author":"Shepard D.S.","year":"2013","unstructured":"Shepard D.S.; Lees R.; Ng C.W.; Undurraga E.A.; Halasa Y.; Lum L.;  burden of dengue in malaysia Report from a collaboration between universities and the ministry of health of malaysia 2013","journal-title":"burden of dengue in malaysia Report from a collaboration between universities and the ministry of health of malaysia"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-443-06668-9.50077-6","author":"Gubler D.","year":"1997","unstructured":"Gubler D.; Kuno G.;  Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem Dengue and dengue hemorrhagic fever 1997,1-22","journal-title":"Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem Dengue and dengue hemorrhagic fever"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.mcna.2008.07.002","volume":"92","author":"Wilder-Smith A.","year":"2008","unstructured":"Wilder-Smith A.; Gubler D.J.; Geographic expansion of dengue: the impact of international travel. Med Clin North Am 2008,92(6),1377-1390, x.","journal-title":"Med Clin North Am"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2149\/tmh.2011-S05","volume":"39","author":"Gubler D.J.","year":"2011","unstructured":"Gubler D.J.; Dengue, urbanization and globalization: the unholy trinity of the 21st century. Trop Med Health 2011,39(4)(Suppl.),3-11","journal-title":"Trop Med Health"},{"key":"ref=9","first-page":"243","volume":"59","author":"Smith C.E.","year":"1956","unstructured":"Smith C.E.; The history of dengue in tropical Asia and its probable relationship to the mosquito Aedes aegypti. J Trop Med Hyg 1956,59(10),243-251","journal-title":"J Trop Med Hyg"},{"key":"ref=10","first-page":"55","volume":"59","author":"Hirsch A.","year":"1883","unstructured":"Hirsch A.;  Dengue, a comparatively new disease: its symptoms handbook of geographical and historical pathology, 1883,59,55-81","journal-title":"Dengue, a comparatively new disease: its symptoms handbook of geographical and historical pathology,"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1056\/NEJM197112232852606","volume":"285","author":"Ehrenkranz N.J.","year":"1971","unstructured":"Ehrenkranz N.J.; Ventura A.K.; Cuadrado R.R.; Pond W.L.; Porter J.E.; Pandemic dengue in Caribbean countries and the southern United States--past, present and potential problems. N Engl J Med 1971,285(26),1460-1469","journal-title":"N Engl J Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1128\/JVI.74.7.3227-3234.2000","volume":"74","author":"Wang E.","year":"2000","unstructured":"Wang E.; Ni H.; Xu R.; Barrett A.D.; Watowich S.J.; Gubler D.J.; Weaver S.C.; Evolutionary relationships of endemic\/epidemic and sylvatic dengue viruses. J Virol 2000,74(7),3227-3234","journal-title":"J Virol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1567-1348(03)00004-2","volume":"3","author":"Holmes E.C.","year":"2003","unstructured":"Holmes E.C.; Twiddy S.S.; The origin, emergence and evolutionary genetics of dengue virus. Infect Genet Evol 2003,3(1),19-28","journal-title":"Infect Genet Evol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrmicro1006","volume":"2","author":"Weaver S.C.","year":"2004","unstructured":"Weaver S.C.; Barrett A.D.; Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol 2004,2(10),789-801","journal-title":"Nat Rev Microbiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1128\/JVI.01826-10","volume":"85","author":"Midgley C.M.","year":"2011","unstructured":"Midgley C.M.; Bajwa-Joseph M.; Vasanawathana S.; Limpitikul W.; Wills B.; Flanagan A.; Waiyaiya E.; Tran H.B.; Cowper A.E.; Chotiyarnwong P.; Grimes J.M.; Yoksan S.; Malasit P.; Simmons C.P.; Mongkolsapaya J.; Screaton G.R.; An in-depth analysis of original antigenic sin in dengue virus infection. J Virol 2011,85(1),410-421","journal-title":"J Virol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4269\/ajtmh.1983.32.154","volume":"32","author":"Halstead S.B.","year":"1983","unstructured":"Halstead S.B.; Rojanasuphot S.; Sangkawibha N.; Original antigenic sin in dengue. Am J Trop Med Hyg 1983,32(1),154-156","journal-title":"Am J Trop Med Hyg"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/265739a0","volume":"265","author":"Halstead S.B.","year":"1977","unstructured":"Halstead S.B.; O\u2019Rourke E.J.; Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977,265(5596),739-741","journal-title":"Nature"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.146.1.201","volume":"146","author":"Halstead S.B.","year":"1977","unstructured":"Halstead S.B.; O\u2019Rourke E.J.; Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 1977,146(1),201-217","journal-title":"J Exp Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"9422","DOI":"10.1073\/pnas.0703498104","volume":"104","author":"Goncalvez A.P.","year":"2007","unstructured":"Goncalvez A.P.; Engle R.E.; St Claire M.; Purcell R.H.; Lai C.-J.; Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci USA 2007,104(22),9422-9427","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1073\/pnas.0832193100","volume":"100","author":"Modis Y.","year":"2003","unstructured":"Modis Y.; Ogata S.; Clements D.; Harrison S.C.; A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 2003,100(12),6986-6991","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Modis Y.","year":"2004","unstructured":"Modis Y.; Ogata S.; Clements D.; Harrison S.C.; Structure of the dengue virus envelope protein after membrane fusion. Nature 2004,427(6972),313-319","journal-title":"Nature"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/sj.emboj.7600064","volume":"23","author":"Bressanelli S.","year":"2004","unstructured":"Bressanelli S.; Stiasny K.; Allison S.L.; Stura E.A.; Duquerroy S.; Lescar J.; Heinz F.X.; Rey F.A.; Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 2004,23(4),728-738","journal-title":"EMBO J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1128\/JVI.66.3.1535-1542.1992","volume":"66","author":"Cahour A.","year":"1992","unstructured":"Cahour A.; Falgout B.; Lai C.J.; Cleavage of the dengue virus polyprotein at the NS3\/NS4A and NS4B\/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A\/NS4B may be processed by a cellular protease. J Virol 1992,66(3),1535-1542","journal-title":"J Virol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1128\/JVI.68.6.3794-3802.1994","volume":"68","author":"Amberg S.M.","year":"1994","unstructured":"Amberg S.M.; Nestorowicz A.; McCourt D.W.; Rice C.M.; NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J Virol 1994,68(6),3794-3802","journal-title":"J Virol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1128\/JVI.69.11.7232-7243.1995","volume":"69","author":"Falgout B.","year":"1995","unstructured":"Falgout B.; Markoff L.; Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum. J Virol 1995,69(11),7232-7243","journal-title":"J Virol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1128\/JVI.65.5.2467-2475.1991","volume":"65","author":"Falgout B.","year":"1991","unstructured":"Falgout B.; Pethel M.; Zhang Y.M.; Lai C.J.; Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol 1991,65(5),2467-2475","journal-title":"J Virol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"24388","DOI":"10.1074\/jbc.M301717200","volume":"278","author":"Uchil P.D.","year":"2003","unstructured":"Uchil P.D.; Satchidanandam V.; Architecture of the flaviviral replication complex. Protease, nuclease, and detergents reveal encasement within double-layered membrane compartments. J Biol Chem 2003,278(27),24388-24398","journal-title":"J Biol Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbrc.2009.05.036","volume":"385","author":"Jiang L.","year":"2009","unstructured":"Jiang L.; Yao H.; Duan X.; Lu X.; Liu Y.; Polypyrimidine tract-binding protein influences negative strand RNA synthesis of dengue virus. Biochem Biophys Res Commun 2009,385(2),187-192","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF01309792","volume":"128","author":"Bartholomeusz A.I.","year":"1993","unstructured":"Bartholomeusz A.I.; Wright P.J.; Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5. Arch Virol 1993,128(1-2),111-121","journal-title":"Arch Virol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","volume":"73","author":"Li H.","year":"1999","unstructured":"Li H.; Clum S.; You S.; Ebner K.E.; Padmanabhan R.; The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol 1999,73(4),3108-3116","journal-title":"J Virol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","volume":"21","author":"Egloff M.P.","year":"2002","unstructured":"Egloff M.P.; Benarroch D.; Selisko B.; Romette J.L.; Canard B.; An RNA cap (nucleoside-2\u2032-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J 2002,21(11),2757-2768","journal-title":"EMBO J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1261\/rna.1609709","volume":"15","author":"Issur M.","year":"2009","unstructured":"Issur M.; Geiss B.J.; Bougie I.; Picard-Jean F.; Despins S.; Mayette J.; Hobdey S.E.; Bisaillon M.; The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure. RNA 2009,15(12),2340-2350","journal-title":"RNA"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1126\/science.1153264","volume":"319","author":"Yu I-M.","year":"2008","unstructured":"Yu I-M.; Zhang W.; Holdaway H.A.; Li L.; Kostyuchenko V.A.; Chipman P.R.; Kuhn R.J.; Rossmann M.G.; Chen J.; Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 2008,319(5871),1834-1837","journal-title":"Science"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.1016\/s0065-3527(00)55005-2","author":"Heinz F. X.","year":"2000","unstructured":"Heinz F. X.; Allison S. L.;  Structures and mechanisms in flavivirus fusion 2000","journal-title":"Structures and mechanisms in flavivirus fusion"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"12101","DOI":"10.1128\/JVI.01637-09","volume":"83","author":"Yu I.M.","year":"2009","unstructured":"Yu I.M.; Holdaway H.A.; Chipman P.R.; Kuhn R.J.; Rossmann M.G.; Chen J.; Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J Virol 2009,83(23),12101-12107","journal-title":"J Virol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1056\/NEJMra1110265","volume":"366","author":"Simmons C.P.","year":"2012","unstructured":"Simmons C.P.; Farrar J.J.; Nguyen V.; Wills B.; Dengue. N Engl J Med 2012,366(15),1423-1432","journal-title":"N Engl J Med"},{"key":"ref=37","author":"Organization W.H.","year":"2009","unstructured":"Organization W.H.;  Research, S P f; Diseases, T i T; Diseases, W H O D o C o N T; Epidemic, W H O; Alert, P, Dengue: guidelines for diagnosis, treatment, prevention and control 2009","journal-title":"Research, S P f; Diseases, T i T; Diseases, W H O D o C o N T; Epidemic, W H O; Alert, P, Dengue: guidelines for diagnosis, treatment, prevention and control"},{"key":"ref=38","author":"Sanofi P.","unstructured":"Sanofi P.;  Sanofi pasteur dengue vaccine approved in Costa Rica","journal-title":"Sanofi pasteur dengue vaccine approved in Costa Rica"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","volume":"372","author":"Villar L.","year":"2015","unstructured":"Villar L.; Dayan G.H.; Arredondo-Garc\u00eda J.L.; Rivera D.M.; Cunha R.; Deseda C.; Reynales H.; Costa M.S.; Morales-Ram\u00edrez J.O.; Carrasquilla G.; Rey L.C.; Dietze R.; Luz K.; Rivas E.; Miranda Montoya M.C.; Cort\u00e9s Supelano M.; Zambrano B.; Langevin E.; Boaz M.; Tornieporth N.; Saville M.; Noriega F.; Group C.Y.D.S.; CYD15 Study Group Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med 2015,372(2),113-123","journal-title":"N Engl J Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","volume":"384","author":"Capeding M.R.","year":"2014","unstructured":"Capeding M.R.; Tran N.H.; Hadinegoro S.R.; Ismail H.I.; Chotpitayasunondh T.; Chua M.N.; Luong C.Q.; Rusmil K.; Wirawan D.N.; Nallusamy R.; Pitisuttithum P.; Thisyakorn U.; Yoon I.K.; van der Vliet D.; Langevin E.; Laot T.; Hutagalung Y.; Frago C.; Boaz M.; Wartel T.A.; Tornieporth N.G.; Saville M.; Bouckenooghe A.; Group C.Y.D.S.; CYD14 Study Group. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 2014,384(9951),1358-1365","journal-title":"Lancet"},{"key":"ref=41","unstructured":"CNN Philippines Staff TIMELINE The Dengvaxia controversy","journal-title":"CNN Philippines Staff TIMELINE The Dengvaxia controversy"},{"key":"ref=42","unstructured":"w.h.o. revised sage recommendation on use of dengue vaccine,  (accessed date: 1st june 2018)."},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1021\/acs.jmedchem.5b01653","volume":"59","author":"Behnam M.A.","year":"2016","unstructured":"Behnam M.A.; Nitsche C.; Boldescu V.; Klein C.D.; the medicinal chemistry of dengue virus. J Med Chem 2016,59(12),5622-5649","journal-title":"J Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12985-017-0761-1","volume":"14","author":"Garc\u00eda L.L.","year":"2017","unstructured":"Garc\u00eda L.L.; Padilla L.; Casta\u00f1o J.C.; Inhibitors compounds of the flavivirus replication process. Virol J 2017,14(1),95","journal-title":"Virol J"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.antiviral.2015.04.010","volume":"119","author":"Lim S.P.","year":"2015","unstructured":"Lim S.P.; Noble C.G.; Shi P.Y.; The dengue virus NS5 protein as a target for drug discovery. Antiviral Res 2015,119,57-67","journal-title":"Antiviral Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","volume":"100","author":"Lim S.P.","year":"2013","unstructured":"Lim S.P.; Wang Q.Y.; Noble C.G.; Chen Y.L.; Dong H.; Zou B.; Yokokawa F.; Nilar S.; Smith P.; Beer D.; Lescar J.; Shi P.Y.; Ten years of dengue drug discovery: progress and prospects. Antiviral Res 2013,100(2),500-519","journal-title":"Antiviral Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.antiviral.2009.12.011","volume":"85","author":"Noble C.G.","year":"2010","unstructured":"Noble C.G.; Chen Y.L.; Dong H.; Gu F.; Lim S.P.; Schul W.; Wang Q.Y.; Shi P.Y.; Strategies for development of Dengue virus inhibitors. Antiviral Res 2010,85(3),450-462","journal-title":"Antiviral Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.antiviral.2012.09.007","volume":"96","author":"Noble C.G.","year":"2012","unstructured":"Noble C.G.; Shi P.Y.; Structural biology of dengue virus enzymes: towards rational design of therapeutics. Antiviral Res 2012,96(2),115-126","journal-title":"Antiviral Res"},{"key":"ref=49","volume":"1","author":"Wangikar P.","year":"2016","unstructured":"Wangikar P.; Martis E.A.F.; Ambre P.K.; Nandan S.; Coutinho E.C.; Update on methyltransferase inhibitors of the dengue virus and further scope in the field. Journal of Infectious Disease and Pathology 2016,1(1)","journal-title":"Journal of Infectious Disease and Pathology"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/femsre\/fuu004","volume":"39","author":"Cruz-Oliveira C.","year":"2015","unstructured":"Cruz-Oliveira C.; Freire J.M.; Concei\u00e7\u00e3o T.M.; Higa L.M.; Castanho M.A.; Da Poian A.T.; Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol Rev 2015,39(2),155-170","journal-title":"FEMS Microbiol Rev"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1073\/pnas.0305892101","volume":"101","author":"Ma L.","year":"2004","unstructured":"Ma L.; Jones C.T.; Groesch T.D.; Kuhn R.J.; Post C.B.; Solution structure of dengue virus capsid protein reveals another fold. Proc Natl Acad Sci USA 2004,101(10),3414-3419","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-virology-110615-042334","volume":"3","author":"Byk L.A.","year":"2016","unstructured":"Byk L.A.; Gamarnik A.V.; Properties and functions of the dengue virus capsid protein. Annu Rev Virol 2016,3(1),263-281","journal-title":"Annu Rev Virol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.coviro.2014.02.002","volume":"5","author":"Klumpp K.","year":"2014","unstructured":"Klumpp K.; Cr\u00e9pin T.; Capsid proteins of enveloped viruses as antiviral drug targets. Curr Opin Virol 2014,5,63-71","journal-title":"Curr Opin Virol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/AAC.01429-12","volume":"57","author":"Byrd C.M.","year":"2013","unstructured":"Byrd C.M.; Dai D.; Grosenbach D.W.; Berhanu A.; Jones K.F.; Cardwell K.B.; Schneider C.; Wineinger K.A.; Page J.M.; Harver C.; Stavale E.; Tyavanagimatt S.; Stone M.A.; Bartenschlager R.; Scaturro P.; Hruby D.E.; Jordan R.; A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob Agents Chemother 2013,57(1),15-25","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"11540","DOI":"10.1128\/JVI.01745-14","volume":"88","author":"Scaturro P.","year":"2014","unstructured":"Scaturro P.; Trist I.M.; Paul D.; Kumar A.; Acosta E.G.; Byrd C.M.; Jordan R.; Brancale A.; Bartenschlager R.; Characterization of the mode of action of a potent dengue virus capsid inhibitor. J Virol 2014,88(19),11540-11555","journal-title":"J Virol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/BJ20112219","volume":"444","author":"Martins I.C.","year":"2012","unstructured":"Martins I.C.; Gomes-Neto F.; Faustino A.F.; Carvalho F.A.; Carneiro F.A.; Bozza P.T.; Mohana-Borges R.; Castanho M.A.; Almeida F.C.; Santos N.C.; Da Poian A.T.; The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif. Biochem J 2012,444(3),405-415","journal-title":"Biochem J"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1126\/science.1153263","volume":"319","author":"Li L.","year":"2008","unstructured":"Li L.; Lok S-M.; Yu I-M.; Zhang Y.; Kuhn R.J.; Chen J.; Rossmann M.G.; The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 2008,319(5871),1830-1834","journal-title":"Science"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nsmb.2463","volume":"20","author":"Zhang X.","year":"2013","unstructured":"Zhang X.; Ge P.; Yu X.; Brannan J.M.; Bi G.; Zhang Q.; Schein S.; Zhou Z.H.; Cryo-EM structure of the mature dengue virus at 3.5-\u00c5 resolution. Nat Struct Mol Biol 2013,20(1),105-110","journal-title":"Nat Struct Mol Biol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/cbdd.12576","volume":"86","author":"Panya A.","year":"2015","unstructured":"Panya A.; Sawasdee N.; Junking M.; Srisawat C.; Choowongkomon K.; Yenchitsomanus P.T.; A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Chem Biol Drug Des 2015,86(5),1093-1104","journal-title":"Chem Biol Drug Des"},{"key":"ref=60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001157","volume":"6","author":"Zheng A.","year":"2010","unstructured":"Zheng A.; Umashankar M.; Kielian M.; In vitro and in vivo studies identify important features of dengue virus pr-E protein interactions. PLoS Pathog 2010,6(10)","journal-title":"PLoS Pathog"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrmicro1067","volume":"3","author":"Mukhopadhyay S.","year":"2005","unstructured":"Mukhopadhyay S.; Kuhn R.J.; Rossmann M.G.; A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 2005,3(1),13-22","journal-title":"Nat Rev Microbiol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1083\/jcb.200306112","volume":"164","author":"Cambi A.","year":"2004","unstructured":"Cambi A.; de Lange F.; van Maarseveen N.M.; Nijhuis M.; Joosten B.; van Dijk E.M.; de Bakker B.I.; Fransen J.A.; Bovee-Geurts P.H.; van Leeuwen F.N.; Van Hulst N.F.; Figdor C.G.; Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. J Cell Biol 2004,164(1),145-155","journal-title":"J Cell Biol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1084\/jem.20021840","volume":"197","author":"Tassaneetrithep B.","year":"2003","unstructured":"Tassaneetrithep B.; Burgess T.H.; Granelli-Piperno A.; Trumpfheller C.; Finke J.; Sun W.; Eller M.A.; Pattanapanyasat K.; Sarasombath S.; Birx D.L.; Steinman R.M.; Schlesinger S.; Marovich M.A.; DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003,197(7),823-829","journal-title":"J Exp Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"Dejnirattisai W.","year":"2015","unstructured":"Dejnirattisai W.; Wongwiwat W.; Supasa S.; Zhang X.; Dai X.; Rouvinski A.; Jumnainsong A.; Edwards C.; Quyen N.T.H.; Duangchinda T.; Grimes J.M.; Tsai W.Y.; Lai C.Y.; Wang W.K.; Malasit P.; Farrar J.; Simmons C.P.; Zhou Z.H.; Rey F.A.; Mongkolsapaya J.; Screaton G.R.; A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol 2015,16(2),170-177","journal-title":"Nat Immunol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e00873","DOI":"10.1128\/mBio.00873-13","volume":"4","author":"Smith S.A.","year":"2013","unstructured":"Smith S.A.; de Alwis A.R.; Kose N.; Harris E.; Ibarra K.D.; Kahle K.M.; Pfaff J.M.; Xiang X.; Doranz B.J.; de Silva A.M.; Austin S.K.; Sukupolvi-Petty S.; Diamond M.S.; Crowe J.E.; Jr. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. MBio 2013,4(6),e00873-e13","journal-title":"MBio"},{"key":"ref=66","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/628475","volume":"2012","author":"Alen M.M.","year":"2012","unstructured":"Alen M.M.; Schols D.; Dengue virus entry as target for antiviral therapy. J Trop Med 2012,2012","journal-title":"J Trop Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tim.2010.04.003","volume":"18","author":"Sayce A.C.","year":"2010","unstructured":"Sayce A.C.; Miller J.L.; Zitzmann N.; Targeting a host process as an antiviral approach against dengue virus. Trends Microbiol 2010,18(7),323-330","journal-title":"Trends Microbiol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3389\/fmicb.2017.01415","volume":"8","author":"Yap S.S.L.","year":"2017","unstructured":"Yap S.S.L.; Nguyen-Khuong T.; Rudd P.M.; Alonso S.; Dengue virus glycosylation: what do we know? Front Microbiol 2017,8,1415","journal-title":"Front Microbiol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.1128\/JVI.00757-13","volume":"87","author":"Fibriansah G.","year":"2013","unstructured":"Fibriansah G.; Ng T.S.; Kostyuchenko V.A.; Lee J.; Lee S.; Wang J.; Lok S.M.; Structural changes in dengue virus when exposed to a temperature of 37\u00b0C. J Virol 2013,87(13),7585-7592","journal-title":"J Virol"},{"key":"ref=70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000428","volume":"2","author":"Yang J.M.","year":"2007","unstructured":"Yang J.M.; Chen Y.F.; Tu Y.Y.; Yen K.R.; Yang Y.L.; Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PLoS One 2007,2(5)","journal-title":"PLoS One"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1021\/cb800176t","volume":"3","author":"Zhou Z.","year":"2008","unstructured":"Zhou Z.; Khaliq M.; Suk J.E.; Patkar C.; Li L.; Kuhn R.J.; Post C.B.; Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. ACS Chem Biol 2008,3(12),765-775","journal-title":"ACS Chem Biol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1021\/jm800412d","volume":"51","author":"Li Z.","year":"2008","unstructured":"Li Z.; Khaliq M.; Zhou Z.; Post C.B.; Kuhn R.J.; Cushman M.; Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins. J Med Chem 2008,51(15),4660-4671","journal-title":"J Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","volume":"84","author":"Kampmann T.","year":"2009","unstructured":"Kampmann T.; Yennamalli R.; Campbell P.; Stoermer M.J.; Fairlie D.P.; Kobe B.; Young P.R.; In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antiviral Res 2009,84(3),234-241","journal-title":"Antiviral Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10822-009-9263-6","volume":"23","author":"Yennamalli R.","year":"2009","unstructured":"Yennamalli R.; Subbarao N.; Kampmann T.; McGeary R.P.; Young P.R.; Kobe B.; Identification of novel target sites and an inhibitor of the dengue virus E protein. J Comput Aided Mol Des 2009,23(6),333-341","journal-title":"J Comput Aided Mol Des"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/AAC.01148-08","volume":"53","author":"Wang Q.Y.","year":"2009","unstructured":"Wang Q.Y.; Patel S.J.; Vangrevelinghe E.; Xu H.Y.; Rao R.; Jaber D.; Schul W.; Gu F.; Heudi O.; Ma N.L.; Poh M.K.; Phong W.Y.; Keller T.H.; Jacoby E.; Vasudevan S.G.; A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother 2009,53(5),1823-1831","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.antiviral.2009.09.011","volume":"84","author":"Poh M.K.","year":"2009","unstructured":"Poh M.K.; Yip A.; Zhang S.; Priestle J.P.; Ma N.L.; Smit J.M.; Wilschut J.; Shi P.Y.; Wenk M.R.; Schul W.; A small molecule fusion inhibitor of dengue virus. Antiviral Res 2009,84(3),260-266","journal-title":"Antiviral Res"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002627","volume":"8","author":"Schmidt A.G.","year":"2012","unstructured":"Schmidt A.G.; Lee K.; Yang P.L.; Harrison S.C.; Small-molecule inhibitors of dengue-virus entry. PLoS Pathog 2012,8(4)","journal-title":"PLoS Pathog"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.chembiol.2016.03.010","volume":"23","author":"Clark M.J.","year":"2016","unstructured":"Clark M.J.; Miduturu C.; Schmidt A.G.; Zhu X.; Pitts J.D.; Wang J.; Potisopon S.; Zhang J.; Wojciechowski A.; Hann Chu J.J.; Gray N.S.; Yang P.L.; gnf-2 inhibits dengue virus by targeting Abl kinases and the viral E protein. Cell Chem Biol 2016,23(4),443-452","journal-title":"Cell Chem Biol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12985-017-0895-1","volume":"14","author":"Abdul Ahmad S.A.","year":"2017","unstructured":"Abdul Ahmad S.A.; Palanisamy U.D.; Tejo B.A.; Chew M.F.; Tham H.W.; Syed Hassan S.; Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication. Virol J 2017,14(1),229","journal-title":"Virol J"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1128\/AAC.00686-10","volume":"54","author":"Kaptein S.J.","year":"2010","unstructured":"Kaptein S.J.; De Burghgraeve T.; Froeyen M.; Pastorino B.; Alen M.M.; Mondotte J.A.; Herdewijn P.; Jacobs M.; de Lamballerie X.; Schols D.; Gamarnik A.V.; Sztaricskai F.; Neyts J.; A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro. Antimicrob Agents Chemother 2010,54(12),5269-5280","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037244","volume":"7","author":"De Burghgraeve T.","year":"2012","unstructured":"De Burghgraeve T.; Kaptein S.J.; Ayala-Nunez N.V.; Mondotte J.A.; Pastorino B.; Printsevskaya S.S.; de Lamballerie X.; Jacobs M.; Preobrazhenskaya M.; Gamarnik A.V.; Smit J.M.; Neyts J.; An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro. PLoS One 2012,7(5)","journal-title":"PLoS One"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1743-422X-2-49","volume":"2","author":"Hrobowski Y.M.","year":"2005","unstructured":"Hrobowski Y.M.; Garry R.F.; Michael S.F.; Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol J 2005,2,49","journal-title":"Virol J"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.biophys.28.1.319","volume":"28","author":"White S.H.","year":"1999","unstructured":"White S.H.; Wimley W.C.; Membrane protein folding and stability: physical principles. Annu Rev Biophys Biomol Struct 1999,28(1),319-365","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1128\/JVI.73.7.5605-5612.1999","volume":"73","author":"Allison S.L.","year":"1999","unstructured":"Allison S.L.; Stiasny K.; Stadler K.; Mandl C.W.; Heinz F.X.; Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol 1999,73(7),5605-5612","journal-title":"J Virol"},{"key":"ref=85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000721","volume":"4","author":"Costin J.M.","year":"2010","unstructured":"Costin J.M.; Jenwitheesuk E.; Lok S.M.; Hunsperger E.; Conrads K.A.; Fontaine K.A.; Rees C.R.; Rossmann M.G.; Isern S.; Samudrala R.; Michael S.F.; Structural optimization and de novo design of dengue virus entry inhibitory peptides. PLoS Negl Trop Dis 2010,4(6)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1006\/jmbi.1997.1479","volume":"275","author":"Samudrala R.","year":"1998","unstructured":"Samudrala R.; Moult J.; An all-atom distance-dependent conditional probability discriminatory function for protein structure prediction. J Mol Biol 1998,275(5),895-916","journal-title":"J Mol Biol"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050995","volume":"7","author":"Lok S.M.","year":"2012","unstructured":"Lok S.M.; Costin J.M.; Hrobowski Y.M.; Hoffmann A.R.; Rowe D.K.; Kukkaro P.; Holdaway H.; Chipman P.; Fontaine K.A.; Holbrook M.R.; Garry R.F.; Kostyuchenko V.; Wimley W.C.; Isern S.; Rossmann M.G.; Michael S.F.; Release of dengue virus genome induced by a peptide inhibitor. PLoS One 2012,7(11)","journal-title":"PLoS One"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.antiviral.2010.11.008","volume":"89","author":"Nicholson C.O.","year":"2011","unstructured":"Nicholson C.O.; Costin J.M.; Rowe D.K.; Lin L.; Jenwitheesuk E.; Samudrala R.; Isern S.; Michael S.F.; Viral entry inhibitors block dengue antibody-dependent enhancement in vitro. Antiviral Res 2011,89(1),71-74","journal-title":"Antiviral Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/prot.24105","volume":"80","author":"Xu Y.","year":"2012","unstructured":"Xu Y.; Rahman N.A.; Othman R.; Hu P.; Huang M.; Computational identification of self-inhibitory peptides from envelope proteins. Proteins 2012,80(9),2154-2168","journal-title":"Proteins"},{"key":"ref=90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000851","volume":"6","author":"Schmidt A.G.","year":"2010","unstructured":"Schmidt A.G.; Yang P.L.; Harrison S.C.; Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog 2010,6(4)","journal-title":"PLoS Pathog"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"12549","DOI":"10.1128\/JVI.01440-10","volume":"84","author":"Schmidt A.G.","year":"2010","unstructured":"Schmidt A.G.; Yang P.L.; Harrison S.C.; Peptide inhibitors of flavivirus entry derived from the E protein stem. J Virol 2010,84(24),12549-12554","journal-title":"J Virol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1128\/JVI.78.1.378-388.2004","volume":"78","author":"Hung J.J.","year":"2004","unstructured":"Hung J.J.; Hsieh M.T.; Young M.J.; Kao C.L.; King C.C.; Chang W.; An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol 2004,78(1),378-388","journal-title":"J Virol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11262-007-0103-2","volume":"35","author":"Mazumder R.","year":"2007","unstructured":"Mazumder R.; Hu Z.Z.; Vinayaka C.R.; Sagripanti J.L.; Frost S.D.; Kosakovsky Pond S.L.; Wu C.H.; Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines. Virus Genes 2007,35(2),175-186","journal-title":"Virus Genes"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1006\/viro.1996.0550","volume":"224","author":"Hiramatsu K.","year":"1996","unstructured":"Hiramatsu K.; Tadano M.; Men R.; Lai C.J.; Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2\/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology 1996,224(2),437-445","journal-title":"Virology"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"719","DOI":"10.7150\/ijms.5037","volume":"10","author":"Alhoot M.A.","year":"2013","unstructured":"Alhoot M.A.; Rathinam A.K.; Wang S.M.; Manikam R.; Sekaran S.D.; Inhibition of dengue virus entry into target cells using synthetic antiviral peptides. Int J Med Sci 2013,10(6),719-729","journal-title":"Int J Med Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/cbdd.12309","volume":"84","author":"Panya A.","year":"2014","unstructured":"Panya A.; Bangphoomi K.; Choowongkomon K.; Yenchitsomanus P.T.; Peptide inhibitors against dengue virus infection. Chem Biol Drug Des 2014,84(2),148-157","journal-title":"Chem Biol Drug Des"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/bib\/bbv008","volume":"16","author":"Rentzsch R.","year":"2015","unstructured":"Rentzsch R.; Renard B.Y.; Docking small peptides remains a great challenge: an assessment using Auto Dock Vina. Brief Bioinform 2015,16(6),1045-1056","journal-title":"Brief Bioinform"},{"key":"ref=98","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1827341","volume":"2017","author":"de la Guardia C.","year":"2017","unstructured":"de la Guardia C.; Quijada M.; Lleonart R.; Phage-displayed peptides selected to bind envelope glycoprotein show antiviral activity against dengue virus serotype 2. Adv Virol 2017,2017","journal-title":"Adv Virol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/jam.12921","volume":"119","author":"Chew M.F.","year":"2015","unstructured":"Chew M.F.; Tham H.W.; Rajik M.; Sharifah S.H.; Anti-dengue virus serotype 2 activity and mode of action of a novel peptide. J Appl Microbiol 2015,119(4),1170-1180","journal-title":"J Appl Microbiol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","volume":"29","author":"De Clercq E.","year":"2016","unstructured":"De Clercq E.; Li G.; Approved antiviral drugs over the past 50 years. Clin Microbiol Rev 2016,29(3),695-747","journal-title":"Clin Microbiol Rev"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/NEJMoa035026","volume":"348","author":"Lalezari J.P.","year":"2003","unstructured":"Lalezari J.P.; Henry K.; O\u2019Hearn M.; Montaner J.S.; Piliero P.J.; Trottier B.; Walmsley S.; Cohen C.; Kuritzkes D.R.; Eron J.J.; Jr.; Chung, J.; DeMasi, R.; Donatacci, L.; Drobnes, C.; Delehanty, J.; Salgo, M.; Group, T.S. TORO 1 Study Group. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med 2003,348(22),2175-2185","journal-title":"N Engl J Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.virol.2008.04.032","volume":"377","author":"Pugach P.","year":"2008","unstructured":"Pugach P.; Ketas T.J.; Michael E.; Moore J.P.; Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors. Virology 2008,377(2),401-407","journal-title":"Virology"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","volume":"58","author":"Volz T.","year":"2013","unstructured":"Volz T.; Allweiss L.; Ben MBarek, M.; Warlich, M.; Lohse, A.W.; Pollok, J.M.; Alexandrov, A.; Urban, S.; Petersen, J.; L\u00fctgehet-mann, M.; Dandri, M. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. J Hepatol 2013,58(5),861-867","journal-title":"J Hepatol"},{"key":"ref=104","author":"Lindenbach B.","year":"2007","unstructured":"Lindenbach B.; Thiel H. J.; Rice C. M.; flaviviridae: the viruses and their replication, 2007"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1073\/pnas.1322036111","volume":"111","author":"Edeling M.A.","year":"2014","unstructured":"Edeling M.A.; Diamond M.S.; Fremont D.H.; Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc Natl Acad Sci USA 2014,111(11),4285-4290","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"9608","DOI":"10.1128\/JVI.71.12.9608-9617.1997","volume":"71","author":"Lindenbach B.D.","year":"1997","unstructured":"Lindenbach B.D.; Rice C.M.; trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol 1997,71(12),9608-9617","journal-title":"J Virol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.virol.2011.02.022","volume":"413","author":"Somnuke P.","year":"2011","unstructured":"Somnuke P.; Hauhart R.E.; Atkinson J.P.; Diamond M.S.; Avirutnan P.; N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. Virology 2011,413(2),253-264","journal-title":"Virology"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","volume":"98","author":"Muller D.A.","year":"2013","unstructured":"Muller D.A.; Young P.R.; The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res 2013,98(2),192-208","journal-title":"Antiviral Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/0042-6822(89)90544-8","volume":"171","author":"Winkler G.","year":"1989","unstructured":"Winkler G.; Maxwell S.E.; Ruemmler C.; Stollar V.; Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 1989,171(1),302-305","journal-title":"Virology"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"6104","DOI":"10.1128\/JVI.73.7.6104-6110.1999","volume":"73","author":"Flamand M.","year":"1999","unstructured":"Flamand M.; Megret F.; Mathieu M.; Lepault J.; Rey F.A.; Deubel V.; Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol 1999,73(7),6104-6110","journal-title":"J Virol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00705-004-0430-8","volume":"150","author":"Crabtree M.B.","year":"2005","unstructured":"Crabtree M.B.; Kinney R.M.; Miller B.R.; Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses. Arch Virol 2005,150(4),771-786","journal-title":"Arch Virol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1099\/0022-1317-75-5-1183","volume":"75","author":"Pryor M.J.","year":"1994","unstructured":"Pryor M.J.; Wright P.J.; Glycosylation mutants of dengue virus NS1 protein. J Gen Virol 1994,75(Pt 5),1183-1187","journal-title":"J Gen Virol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11262-008-0211-7","volume":"36","author":"Tajima S.","year":"2008","unstructured":"Tajima S.; Takasaki T.; Kurane I.; Characterization of Asn130-to-Ala mutant of dengue type 1 virus NS1 protein. Virus Genes 2008,36(2),323-329","journal-title":"Virus Genes"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1128\/JVI.73.6.4611-4621.1999","volume":"73","author":"Lindenbach B.D.","year":"1999","unstructured":"Lindenbach B.D.; Rice C.M.; Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J Virol 1999,73(6),4611-4621","journal-title":"J Virol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"7360","DOI":"10.1128\/JVI.00157-12","volume":"86","author":"Youn S.","year":"2012","unstructured":"Youn S.; Li T.; McCune B.T.; Edeling M.A.; Fremont D.H.; Cristea I.M.; Diamond M.S.; Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus. J Virol 2012,86(13),7360-7371","journal-title":"J Virol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1086\/500949","volume":"193","author":"Avirutnan P.","year":"2006","unstructured":"Avirutnan P.; Punyadee N.; Noisakran S.; Komoltri C.; Thiemmeca S.; Auethavornanan K.; Jairungsri A.; Kanlaya R.; Tangthawornchaikul N.; Puttikhunt C.; Pattanakitsakul S.N.; Yenchitsomanus P.T.; Mongkolsapaya J.; Kasinrerk W.; Sittisombut N.; Husmann M.; Blettner M.; Vasanawathana S.; Bhakdi S.; Malasit P.; Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 2006,193(8),1078-1088","journal-title":"J Infect Dis"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","volume":"92","author":"Rathore A.P.","year":"2011","unstructured":"Rathore A.P.; Paradkar P.N.; Watanabe S.; Tan K.H.; Sung C.; Connolly J.E.; Low J.; Ooi E.E.; Vasudevan S.G.; Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model. Antiviral Res 2011,92(3),453-460","journal-title":"Antiviral Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.1247749","volume":"343","author":"Akey D.L.","year":"2014","unstructured":"Akey D.L.; Brown W.C.; Dutta S.; Konwerski J.; Jose J.; Jurkiw T.J.; DelProposto J.; Ogata C.M.; Skiniotis G.; Kuhn R.J.; Smith J.L.; Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 2014,343(6173),881-885","journal-title":"Science"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1128\/JVI.02424-12","volume":"87","author":"Xie X.","year":"2013","unstructured":"Xie X.; Gayen S.; Kang C.; Yuan Z.; Shi P.Y.; Membrane topology and function of dengue virus NS2A protein. J Virol 2013,87(8),4609-4622","journal-title":"J Virol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1128\/JVI.00002-08","volume":"82","author":"Leung J.Y.","year":"2008","unstructured":"Leung J.Y.; Pijlman G.P.; Kondratieva N.; Hyde J.; Mackenzie J.M.; Khromykh A.A.; Role of nonstructural protein NS2A in flavivirus assembly. J Virol 2008,82(10),4731-4741","journal-title":"J Virol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"14333","DOI":"10.1073\/pnas.2335168100","volume":"100","author":"Mu\u00f1oz-Jordan J.L.","year":"2003","unstructured":"Mu\u00f1oz-Jordan J.L.; S\u00e1nchez-Burgos G.G.; Laurent-Rolle M.; Garc\u00eda-Sastre A.; Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA 2003,100(24),14333-14338","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"e01836","DOI":"10.1128\/JVI.01836-16","volume":"91","author":"Wu R.H.","year":"2017","unstructured":"Wu R.H.; Tsai M.H.; Tsai K.N.; Tian J.N.; Wu J.S.; Wu S.Y.; Chern J.H.; Chen C.H.; Yueh A.; Mutagenesis of dengue virus protein NS2A revealed a novel domain responsible for virus-induced cytopathic effect and interactions between NS2A and NS2B transmembrane segments. J Virol 2017,91(12),e01836-e16","journal-title":"J Virol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1128\/JVI.03011-14","volume":"89","author":"Wu R.H.","year":"2015","unstructured":"Wu R.H.; Tsai M.H.; Chao D.Y.; Yueh A.; Scanning mutagenesis studies reveal a potential intramolecular interaction within the C-terminal half of dengue virus NS2A involved in viral RNA replication and virus assembly and secretion. J Virol 2015,89(8),4281-4295","journal-title":"J Virol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.bbamem.2017.10.016","volume":"1860","author":"Li Y.","year":"2018","unstructured":"Li Y.; Lee M.Y.; Loh Y.R.; Kang C.; Secondary structure and membrane topology of dengue virus NS4A protein in micelles. Biochim Biophys Acta Biomembr 2018,1860(2),442-450","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"8873","DOI":"10.1074\/jbc.M609919200","volume":"282","author":"Miller S.","year":"2007","unstructured":"Miller S.; Kastner S.; Krijnse-Locker J.; B\u00fchler S.; Bartenschlager R.; The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J Biol Chem 2007,282(12),8873-8882","journal-title":"J Biol Chem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1128\/JVI.01249-13","volume":"88","author":"Teo C.S.","year":"2014","unstructured":"Teo C.S.; Chu J.J.; Cellular vimentin regulates construction of dengue virus replication complexes through interaction with NS4A protein. J Virol 2014,88(4),1897-1913","journal-title":"J Virol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1128\/JVI.00546-15","volume":"89","author":"Lee C.M.","year":"2015","unstructured":"Lee C.M.; Xie X.; Zou J.; Li S.H.; Lee M.Y.; Dong H.; Qin C.F.; Kang C.; Shi P.Y.; Determinants of dengue virus NS4A protein oligomerization. J Virol 2015,89(12),6171-6183","journal-title":"J Virol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1128\/JVI.01900-12","volume":"87","author":"Stern O.","year":"2013","unstructured":"Stern O.; Hung Y.F.; Valdau O.; Yaffe Y.; Harris E.; Hoffmann S.; Willbold D.; Sklan E.H.; An N-terminal amphipathic helix in dengue virus nonstructural protein 4A mediates oligomerization and is essential for replication. J Virol 2013,87(7),4080-4085","journal-title":"J Virol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"22147","DOI":"10.1074\/jbc.M110.192500","volume":"286","author":"McLean J.E.","year":"2011","unstructured":"McLean J.E.; Wudzinska A.; Datan E.; Quaglino D.; Zakeri Z.; Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication. J Biol Chem 2011,286(25),22147-22159","journal-title":"J Biol Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1128\/JVI.03453-14","volume":"89","author":"Zou J.","year":"2015","unstructured":"Zou J.; Xie X.; Wang Q.Y.; Dong H.; Lee M.Y.; Kang C.; Yuan Z.; Shi P.Y.; Characterization of dengue virus NS4A and NS4B protein interaction. J Virol 2015,89(7),3455-3470","journal-title":"J Virol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/cmdc.201300505","volume":"9","author":"Wang P.","year":"2014","unstructured":"Wang P.; Li L.F.; Wang Q.Y.; Shang L.Q.; Shi P.Y.; Yin Z.; Anti-dengue-virus activity and structure-activity relationship studies of lycorine derivatives. Chem Med Chem 2014,9(7),1522-1533","journal-title":"Chem Med Chem"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/rmv.1835","volume":"25","author":"Zmurko J.","year":"2015","unstructured":"Zmurko J.; Neyts J.; Dallmeier K.; Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention. Rev Med Virol 2015,25(4),205-223","journal-title":"Rev Med Virol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2015.03.007","volume":"118","author":"Xie X.","year":"2015","unstructured":"Xie X.; Zou J.; Wang Q.Y.; Shi P.Y.; Targeting dengue virus NS4B protein for drug discovery. Antiviral Res 2015,118,39-45","journal-title":"Antiviral Res"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"8854","DOI":"10.1074\/jbc.M512697200","volume":"281","author":"Miller S.","year":"2006","unstructured":"Miller S.; Sparacio S.; Bartenschlager R.; Subcellular localization and membrane topology of the Dengue virus type 2 Non-structural protein 4B. J Biol Chem 2006,281(13),8854-8863","journal-title":"J Biol Chem"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1128\/JVI.02782-13","volume":"88","author":"Zou J.","year":"2014","unstructured":"Zou J.; Xie X.; Lee T.; Chandrasekaran R.; Reynaud A.; Yap L.; Wang Q.Y.; Dong H.; Kang C.; Yuan Z.; Lescar J.; Shi P.Y.; Dimerization of flavivirus NS4B protein. J Virol 2014,88(6),3379-3391","journal-title":"J Virol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"11183","DOI":"10.1128\/JVI.05468-11","volume":"85","author":"Xie X.","year":"2011","unstructured":"Xie X.; Wang Q.Y.; Xu H.Y.; Qing M.; Kramer L.; Yuan Z.; Shi P.Y.; Inhibition of dengue virus by targeting viral NS4B protein. J Virol 2011,85(21),11183-11195","journal-title":"J Virol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1099\/vir.0.81844-0","volume":"87","author":"Umareddy I.","year":"2006","unstructured":"Umareddy I.; Chao A.; Sampath A.; Gu F.; Vasudevan S.G.; Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA. J Gen Virol 2006,87(Pt 9),2605-2614","journal-title":"J Gen Virol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.antiviral.2013.05.011","volume":"99","author":"van Cleef K.W.","year":"2013","unstructured":"van Cleef K.W.; Overheul G.J.; Thomassen M.C.; Kaptein S.J.; Davidson A.D.; Jacobs M.; Neyts J.; van Kuppeveld F.J.; van Rij R.P.; Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication. Antiviral Res 2013,99(2),165-171","journal-title":"Antiviral Res"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1128\/JVI.00855-15","volume":"89","author":"Wang Q.Y.","year":"2015","unstructured":"Wang Q.Y.; Dong H.; Zou B.; Karuna R.; Wan K.F.; Zou J.; Susila A.; Yip A.; Shan C.; Yeo K.L.; Xu H.; Ding M.; Chan W.L.; Gu F.; Seah P.G.; Liu W.; Lakshminarayana S.B.; Kang C.; Lescar J.; Blasco F.; Smith P.W.; Shi P.Y.; Discovery of Dengue virus NS4B inhibitors. J Virol 2015,89(16),8233-8244","journal-title":"J Virol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/bip.10230","volume":"66","author":"Bianchi E.","year":"2002","unstructured":"Bianchi E.; Pessi A.; Inhibiting viral proteases: challenges and opportunities. Biopolymers 2002,66(2),101-114","journal-title":"Biopolymers"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1006\/viro.1993.1198","volume":"193","author":"Arias C.F.","year":"1993","unstructured":"Arias C.F.; Preugschat F.; Strauss J.H.; Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain. Virology 1993,193(2),888-899","journal-title":"Virology"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"9963","DOI":"10.1074\/jbc.275.14.9963","volume":"275","author":"Yusof R.","year":"2000","unstructured":"Yusof R.; Clum S.; Wetzel M.; Murthy H.M.K.; Padmanabhan R.; Purified NS2B\/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J Biol Chem 2000,275(14),9963-9969","journal-title":"J Biol Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/viro.1994.1103","volume":"199","author":"Nestorowicz A.","year":"1994","unstructured":"Nestorowicz A.; Chambers T.J.; Rice C.M.; Mutagenesis of the yellow fever virus NS2A\/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein. Virology 1994,199(1),114-123","journal-title":"Virology"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"45762","DOI":"10.1074\/jbc.M107360200","volume":"276","author":"Leung D.","year":"2001","unstructured":"Leung D.; Schroder K.; White H.; Fang N.X.; Stoermer M.J.; Abbenante G.; Martin J.L.; Young P.R.; Fairlie D.P.; Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem 2001,276(49),45762-45771","journal-title":"J Biol Chem"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.bbrc.2005.03.107","volume":"330","author":"Chanprapaph S.","year":"2005","unstructured":"Chanprapaph S.; Saparpakorn P.; Sangma C.; Niyomrattanakit P.; Hannongbua S.; Angsuthanasombat C.; Katzenmeier G.; Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites. Biochem Biophys Res Commun 2005,330(4),1237-1246","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bmcl.2005.09.062","volume":"16","author":"Yin Z.","year":"2006","unstructured":"Yin Z.; Patel S.J.; Wang W.L.; Wang G.; Chan W.L.; Rao K.R.R.; Alam J.; Jeyaraj D.A.; Ngew X.; Patel V.; Beer D.; Lim S.P.; Vasudevan S.G.; Keller T.H.; Peptide inhibitors of dengue virus NS3 protease. Part 1: Warhead. Bioorg Med Chem Lett 2006,16(1),36-39","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bmcl.2005.09.049","volume":"16","author":"Yin Z.","year":"2006","unstructured":"Yin Z.; Patel S.J.; Wang W.L.; Chan W.L.; Rao R. K.R.; Wang G.; Ngew X.; Patel V.; Beer D.; Knox J.E.; Ma N.L.; Ehrhardt C.; Lim S.P.; Vasudevan S.G.; Keller T.H.; Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors. Bioorg Med Chem Lett 2006,16(1),40-43","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1128\/JVI.06225-11","volume":"86","author":"Noble C.G.","year":"2012","unstructured":"Noble C.G.; Seh C.C.; Chao A.T.; Shi P.Y.; Ligand-bound structures of the dengue virus protease reveal the active conformation. J Virol 2012,86(1),438-446","journal-title":"J Virol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.antiviral.2011.07.002","volume":"92","author":"Sch\u00fcller A.","year":"2011","unstructured":"Sch\u00fcller A.; Yin Z.; Brian Chia C.S.; Doan D.N.P.; Kim H.K.; Shang L.; Loh T.P.; Hill J.; Vasudevan S.G.; Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease. Antiviral Res 2011,92(1),96-101","journal-title":"Antiviral Res"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.antiviral.2012.02.008","volume":"94","author":"Nitsche C.","year":"2012","unstructured":"Nitsche C.; Behnam M.A.M.; Steuer C.; Klein C.D.; Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease. Antiviral Res 2012,94(1),72-79","journal-title":"Antiviral Res"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"8389","DOI":"10.1021\/jm400828u","volume":"56","author":"Nitsche C.","year":"2013","unstructured":"Nitsche C.; Schreier V.N.; Behnam M.A.M.; Kumar A.; Bartenschlager R.; Klein C.D.; Thiazolidinone-peptide hybrids as Dengue virus protease inhibitors with antiviral activity in cell culture. J Med Chem 2013,56(21),8389-8403","journal-title":"J Med Chem"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1021\/ml500245v","volume":"5","author":"Behnam M.A.M.","year":"2014","unstructured":"Behnam M.A.M.; Nitsche C.; Vechi S.M.; Klein C.D.; C-terminal residue optimization and fragment merging: discovery of a potent Peptide-hybrid inhibitor of dengue protease. ACS Med Chem Lett 2014,5(9),1037-1042","journal-title":"ACS Med Chem Lett"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1016\/j.bmc.2015.07.012","volume":"23","author":"Bastos Lima A.","year":"2015","unstructured":"Bastos Lima A.; Behnam M.A.M.; El Sherif Y.; Nitsche C.; Vechi S.M.; Klein C.D.; Dual inhibitors of the Dengue and West Nile virus NS2B-NS3 proteases: synthesis, biological evaluation and docking studies of novel peptide-hybrids. Bioorg Med Chem 2015,23(17),5748-5755","journal-title":"Bioorg Med Chem"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1021\/acs.jmedchem.5b01441","volume":"58","author":"Behnam M.A.M.","year":"2015","unstructured":"Behnam M.A.M.; Graf D.; Bartenschlager R.; Zlotos D.P.; Klein C.D.; Discovery of nanomolar Dengue and West Nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue. J Med Chem 2015,58(23),9354-9370","journal-title":"J Med Chem"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1021\/acs.jmedchem.5b00612","volume":"58","author":"Weigel L.F.","year":"2015","unstructured":"Weigel L.F.; Nitsche C.; Graf D.; Bartenschlager R.; Klein C.D.; Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors. J Med Chem 2015,58(19),7719-7733","journal-title":"J Med Chem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1021\/acs.jmedchem.6b01021","volume":"60","author":"Nitsche C.","year":"2017","unstructured":"Nitsche C.; Zhang L.; Weigel L.F.; Schilz J.; Graf D.; Bartenschlager R.; Hilgenfeld R.; Klein C.D.; Peptide-boronic acid inhibitors of flaviviral proteases: medicinal chemistry and structural biology. J Med Chem 2017,60(1),511-516","journal-title":"J Med Chem"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1016\/j.bmcl.2013.10.071","volume":"23","author":"Zhou G.C.","year":"2013","unstructured":"Zhou G.C.; Weng Z.; Shao X.; Liu F.; Nie X.; Liu J.; Wang D.; Wang C.; Guo K.; Discovery and SAR studies of methionine-proline anilides as Dengue virus NS2B-NS3 protease inhibitors. Bioorg Med Chem Lett 2013,23(24),6549-6554","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ejmech.2016.09.063","volume":"125","author":"Weng Z.","year":"2017","unstructured":"Weng Z.; Shao X.; Graf D.; Wang C.; Klein C.D.; Wang J.; Zhou G.C.; Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors. Eur J Med Chem 2017,125,751-759","journal-title":"Eur J Med Chem"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1016\/j.bmc.2008.08.081","volume":"16","author":"Prusis P.","year":"2008","unstructured":"Prusis P.; Lapins M.; Yahorava S.; Petrovska R.; Niyomrattanakit P.; Katzenmeier G.; Wikberg J.E.S.; Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases. Bioorg Med Chem 2008,16(20),9369-9377","journal-title":"Bioorg Med Chem"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.bbrc.2013.03.139","volume":"434","author":"Prusis P.","year":"2013","unstructured":"Prusis P.; Junaid M.; Petrovska R.; Yahorava S.; Yahorau A.; Katzenmeier G.; Lapins M.; Wikberg J.E.; Design and evaluation of substrate-based octapeptide and non substrate-based tetrapeptide inhibitors of dengue virus NS2B-NS3 proteases. Biochem Biophys Res Commun 2013,434(4),767-772","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2180-14-140","volume":"14","author":"Rothan H.A.","year":"2014","unstructured":"Rothan H.A.; Bahrani H.; Rahman N.A.; Yusof R.; Identification of natural antimicrobial agents to treat dengue infection: in vitro analysis of latarcin peptide activity against dengue virus. BMC Microbiol 2014,14,140","journal-title":"BMC Microbiol"},{"key":"ref=162","author":"Cui T.A.","year":"2007","unstructured":"Cui T.A.; Puah C.M.; Liew O.W.; Lee S.H.;  Novel polypeptides for anti-viral treatment 2007","journal-title":"Novel polypeptides for anti-viral treatment"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.bmc.2009.12.026","volume":"18","author":"Gao Y.","year":"2010","unstructured":"Gao Y.; Cui T.; Lam Y.; Synthesis and disulfide bond connectivity-activity studies of a kalata B1-inspired cyclopeptide against dengue NS2B-NS3 protease. Bioorg Med Chem 2010,18(3),1331-1336","journal-title":"Bioorg Med Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1021\/jm300655h","volume":"55","author":"Xu S.","year":"2012","unstructured":"Xu S.; Li H.; Shao X.; Fan C.; Ericksen B.; Liu J.; Chi C.; Wang C.; Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease. J Med Chem 2012,55(15),6881-6887","journal-title":"J Med Chem"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1471-2334-12-314","volume":"12","author":"Rothan H.A.","year":"2012","unstructured":"Rothan H.A.; Han H.C.; Ramasamy T.S.; Othman S.; Rahman N.A.; Yusof R.; Inhibition of dengue NS2B-NS3 protease and viral replication in vero cells by recombinant retrocyclin-1. BMC Infect Dis 2012,12,314","journal-title":"BMC Infect Dis"},{"key":"ref=166","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/251482","author":"Rothan H.A.","year":"2012","unstructured":"Rothan H.A.; Abdulrahman A.Y.; Sasikumer P.G.; Othman S.; Rahman N.A.; Yusof R.; Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells. J Biomed Biotechnol 2012","journal-title":"J Biomed Biotechnol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/omi.2013.0056","volume":"17","author":"Rothan H.A.","year":"2013","unstructured":"Rothan H.A.; Mohamed Z.; Suhaeb A.M.; Rahman N.A.; Yusof R.; Antiviral cationic peptides as a strategy for innovation in global health therapeutics for Dengue virus: high yield production of the biologically active recombinant plectasin peptide. OMICS 2013,17(11),560-567","journal-title":"OMICS"},{"key":"ref=168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094561","volume":"9","author":"Rothan H.A.","year":"2014","unstructured":"Rothan H.A.; Bahrani H.; Mohamed Z.; Abd Rahman N.; Yusof R.; Fusion of protegrin-1 and plectasin to MAP30 shows significant inhibition activity against dengue virus replication. PLoS One 2014,9(4)","journal-title":"PLoS One"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"e00045","DOI":"10.1128\/JVI.00045-17","volume":"91","author":"Lin K.H.","year":"2017","unstructured":"Lin K.H.; Ali A.; Rusere L.; Soumana D.I.; Kurt Yilmaz N.; Schiffer C.A.; Dengue virus NS2B\/NS3 protease inhibitors exploiting the prime side. J Virol 2017,91(10),e00045-e17","journal-title":"J Virol"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1016\/j.bmcl.2017.05.027","volume":"27","author":"Takagi Y.","year":"2017","unstructured":"Takagi Y.; Matsui K.; Nobori H.; Maeda H.; Sato A.; Kurosu T.; Orba Y.; Sawa H.; Hattori K.; Higashino K.; Numata Y.; Yoshida Y.; Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity. Bioorg Med Chem Lett 2017,27(15),3586-3590","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"85938","DOI":"10.1039\/C5RA14469H","volume":"5","author":"Bhakat S.","year":"2015","unstructured":"Bhakat S.; Delang L.; Kaptein S.; Neyts J.; Leyssen P.; Jayaprakash V.; Reaching beyond HIV\/HCV: nelfinavir as a potential starting point for broad-spectrum protease inhibitors against Dengue and Chikungunya virus. Rsc Adv 2015,5(104),85938-85949","journal-title":"Rsc Adv"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1080\/14756366.2017.1306521","volume":"32","author":"Kouretova J.","year":"2017","unstructured":"Kouretova J.; Hammamy M.Z.; Epp A.; Hardes K.; Kallis S.; Zhang L.; Hilgenfeld R.; Bartenschlager R.; Steinmetzer T.; Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication. J Enzyme Inhib Med Chem 2017,32(1),712-721","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1016\/j.bmcl.2005.12.075","volume":"16","author":"Kiat T.S.","year":"2006","unstructured":"Kiat T.S.; Pippen R.; Yusof R.; Ibrahim H.; Khalid N.; Rahman N.A.; Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. Bioorg Med Chem Lett 2006,16(12),3337-3340","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1021\/ci700388k","volume":"48","author":"Othman R.","year":"2008","unstructured":"Othman R.; Kiat T.S.; Khalid N.; Yusof R.; Newhouse E.I.; Newhouse J.S.; Alam M.; Rahman N.A.; Docking of noncompetitive inhibitors into Dengue virus type 2 protease: understanding the interactions with allosteric binding sites. J Chem Inf Model 2008,48(8),1582-1591","journal-title":"J Chem Inf Model"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cbdd.12122","volume":"82","author":"Heh C.H.","year":"2013","unstructured":"Heh C.H.; Othman R.; Buckle M.J.C.; Sharifuddin Y.; Yusof R.; Rahman N.A.; Rational discovery of dengue type 2 non-competitive inhibitors. Chem Biol Drug Des 2013,82(1),1-11","journal-title":"Chem Biol Drug Des"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.bmc.2014.12.015","volume":"23","author":"de Sousa L.R.F.","year":"2015","unstructured":"de Sousa L.R.F.; Wu H.; Nebo L.; Fernandes J.B.; da Silva M.F.D.F.; Kiefer W.; Kanitz M.; Bodem J.; Diederich W.E.; Schirmeister T.; Vieira P.C.; Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies. Bioorg Med Chem 2015,23(3),466-470","journal-title":"Bioorg Med Chem"},{"key":"ref=177","author":"Shen X.","year":"2016","unstructured":"Shen X.; Chen J.; Lee J.; Mao F.; use of procyanidin in preparation of drugs for treatment of diseases caused by dengue virus infection, china. patent cn105748462a, 2016"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.apsb.2017.04.009","volume":"7","author":"Osman H.","year":"2017","unstructured":"Osman H.; Idris N.H.; Kamarulzaman E.E.; Wahab H.A.; Hassan M.Z.; 3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors. Acta Pharm Sin B 2017,7(4),479-484","journal-title":"Acta Pharm Sin B"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3851\/IMP1767","volume":"21","author":"Cregar-Hernandez L.","year":"2011","unstructured":"Cregar-Hernandez L.; Jiao G-S.; Johnson A.T.; Lehrer A.T.; Wong T.A.S.; Margosiak S.A.; Small molecule pan-dengue and West Nile virus NS3 protease inhibitors. Antivir Chem Chemother 2011,21(5),209-217","journal-title":"Antivir Chem Chemother"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1016\/j.bmc.2011.10.061","volume":"19","author":"Nitsche C.","year":"2011","unstructured":"Nitsche C.; Steuer C.; Klein C.D.; Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases. Bioorg Med Chem 2011,19(24),7318-7337","journal-title":"Bioorg Med Chem"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1016\/j.bmc.2012.04.055","volume":"20","author":"Aravapalli S.","year":"2012","unstructured":"Aravapalli S.; Lai H.; Teramoto T.; Alliston K.R.; Lushington G.H.; Ferguson E.L.; Padmanabhan R.; Groutas W.C.; Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold. Bioorg Med Chem 2012,20(13),4140-4148","journal-title":"Bioorg Med Chem"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.bmc.2011.12.047","volume":"20","author":"Tiew K.C.","year":"2012","unstructured":"Tiew K.C.; Dou D.; Teramoto T.; Lai H.; Alliston K.R.; Lushington G.H.; Padmanabhan R.; Groutas W.C.; Inhibition of Dengue virus and West Nile virus proteases by click chemistry-derived benz[d]isothiazol-3(2H)-one derivatives. Bioorg Med Chem 2012,20(3),1213-1221","journal-title":"Bioorg Med Chem"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"Irwin J.J.","year":"2005","unstructured":"Irwin J.J.; Shoichet B.K.; ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005,45(1),177-182","journal-title":"J Chem Inf Model"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.antiviral.2012.10.009","volume":"97","author":"Lai H.","year":"2013","unstructured":"Lai H.; Sridhar Prasad G.; Padmanabhan R.; Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro. Antiviral Res 2013,97(1),74-80","journal-title":"Antiviral Res"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bmc.2012.10.058","volume":"21","author":"Lai H.","year":"2013","unstructured":"Lai H.; Dou D.; Aravapalli S.; Teramoto T.; Lushington G.H.; Mwania T.M.; Alliston K.R.; Eichhorn D.M.; Padmanabhan R.; Groutas W.C.; Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B\/NS3 proteases. Bioorg Med Chem 2013,21(1),102-113","journal-title":"Bioorg Med Chem"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1016\/j.bmc.2014.09.057","volume":"22","author":"Liu H.","year":"2014","unstructured":"Liu H.; Wu R.; Sun Y.; Ye Y.; Chen J.; Luo X.; Shen X.; Liu H.; Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B\/NS3 protease. Bioorg Med Chem 2014,22(22),6344-6352","journal-title":"Bioorg Med Chem"},{"key":"ref=187","author":"Padmanabhan R.","unstructured":"Padmanabhan R.; Nagarajan K.; Rao K. S.; Shridhara K.; shashiprabha; harisha, a. s., dengue and west nile virus protease inhibitors. pct int. appl., 2014, wo 2014164667 a1 20141009."},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bioorg.2015.07.005","volume":"62","author":"Timiri A.K.","year":"2015","unstructured":"Timiri A.K.; Selvarasu S.; Kesherwani M.; Vijayan V.; Sinha B.N.; Devadasan V.; Jayaprakash V.; Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors. Bioorg Chem 2015,62,74-82","journal-title":"Bioorg Chem"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1128\/AAC.03543-14","volume":"59","author":"Wu H.","year":"2015","unstructured":"Wu H.; Bock S.; Snitko M.; Berger T.; Weidner T.; Holloway S.; Kanitz M.; Diederich W.E.; Steuber H.; Walter C.; Hofmann D.; Wei\u00dfbrich B.; Spannaus R.; Acosta E.G.; Bartenschlager R.; Engels B.; Schirmeister T.; Bodem J.; Novel dengue virus NS2B\/NS3 protease inhibitors. Antimicrob Agents Chemother 2015,59(2),1100-1109","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/14756366.2017.1355791","volume":"32","author":"Pelliccia S.","year":"2017","unstructured":"Pelliccia S.; Wu Y.H.; Coluccia A.; La Regina G.; Tseng C.K.; Famiglini V.; Masci D.; Hiscott J.; Lee J.C.; Silvestri R.; Inhibition of Dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities. J Enzyme Inhib Med Chem 2017,32(1),1091-1101","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=191","first-page":"681","volume":"30","author":"Rothan H.A.","year":"2013","unstructured":"Rothan H.A.; Buckle M.J.; Ammar Y.A.; Mohammadjavad P.; Shatrah O.; Noorsaadah A.R.; Rohana Y.; Study the antiviral activity of some derivatives of tetracycline and non-steroid anti-inflammatory drugs towards Dengue virus. Trop Biomed 2013,30(4),681-690","journal-title":"Trop Biomed"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/aps.2015.56","volume":"36","author":"Wu D.W.","year":"2015","unstructured":"Wu D.W.; Mao F.; Ye Y.; Li J.; Xu C.L.; Luo X.M.; Chen J.; Shen X.; Policresulen, a novel NS2B\/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells. Acta Pharmacol Sin 2015,36(9),1126-1136","journal-title":"Acta Pharmacol Sin"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","volume":"150","author":"Li Z.","year":"2018","unstructured":"Li Z.; Sakamuru S.; Huang R.; Brecher M.; Koetzner C.A.; Zhang J.; Chen H.; Qin C.F.; Zhang Q.-Y.; Zhou J.; Kramer L.D.; Xia M.; Li H.; Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease. Antiviral Res 2018,150,217-225","journal-title":"Antiviral Res"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/AAC.00855-10","volume":"55","author":"Yang C.C.","year":"2011","unstructured":"Yang C.C.; Hsieh Y.C.; Lee S.J.; Wu S.H.; Liao C.L.; Tsao C.H.; Chao Y.S.; Chern J.H.; Wu C.P.; Yueh A.; Novel dengue virus-specific NS2B\/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay. Antimicrob Agents Chemother 2011,55(1),229-238","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.antiviral.2016.08.014","volume":"134","author":"Balasubramanian A.","year":"2016","unstructured":"Balasubramanian A.; Manzano M.; Teramoto T.; Pilankatta R.; Padmanabhan R.; High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Antiviral Res 2016,134,6-16","journal-title":"Antiviral Res"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.antiviral.2009.02.190","volume":"82","author":"Tomlinson S.M.","year":"2009","unstructured":"Tomlinson S.M.; Malmstrom R.D.; Russo A.; Mueller N.; Pang Y-P.; Watowich S.J.; Structure-based discovery of dengue virus protease inhibitors. Antiviral Res 2009,82(3),110-114","journal-title":"Antiviral Res"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.antiviral.2010.12.006","volume":"89","author":"Tomlinson S.M.","year":"2011","unstructured":"Tomlinson S.M.; Watowich S.J.; Anthracene-based inhibitors of dengue virus NS2B-NS3 protease. Antiviral Res 2011,89(2),127-135","journal-title":"Antiviral Res"},{"key":"ref=198","author":"Watowich S.J.","year":"2013","unstructured":"Watowich S.J.; Tomlinson S.M.; Gilbertson S.; smallmolecule inhibitors of dengue and west nile virus proteases. u.s. pat. appl. publ., us 20130035284 a1 20130207, 2013"},{"key":"ref=199","author":"Watowich S.J.","year":"2015","unstructured":"Watowich S.J.; Viswanathan U.; small-molecule inhibitors of dengue virus proteases. u.s. pat. appl. publ., us 20150141521 a1 20150521, 2015"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1021\/ci500531r","volume":"54","author":"Viswanathan U.","year":"2014","unstructured":"Viswanathan U.; Tomlinson S.M.; Fonner J.M.; Mock S.A.; Watowich S.J.; Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal. J Chem Inf Model 2014,54(10),2816-2825","journal-title":"J Chem Inf Model"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.antiviral.2011.12.003","volume":"93","author":"Tomlinson S.M.","year":"2012","unstructured":"Tomlinson S.M.; Watowich S.J.; Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors. Antiviral Res 2012,93(2),245-252","journal-title":"Antiviral Res"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1021\/jm300146f","volume":"55","author":"Deng J.","year":"2012","unstructured":"Deng J.; Li N.; Liu H.; Zuo Z.; Liew O.W.; Xu W.; Chen G.; Tong X.; Tang W.; Zhu J.; Zuo J.; Jiang H.; Yang C.G.; Li J.; Zhu W.; Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping. J Med Chem 2012,55(14),6278-6293","journal-title":"J Med Chem"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bbrc.2013.09.078","volume":"440","author":"Pambudi S.","year":"2013","unstructured":"Pambudi S.; Kawashita N.; Phanthanawiboon S.; Omokoko M.D.; Masrinoul P.; Yamashita A.; Limkittikul K.; Yasunaga T.; Takagi T.; Ikuta K.; Kurosu T.; A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication. Biochem Biophys Res Commun 2013,440(3),393-398","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"15600","DOI":"10.3390\/molecules181215600","volume":"18","author":"Nguyen T.T.H.","year":"2013","unstructured":"Nguyen T.T.H.; Lee S.; Wang H.K.; Chen H.Y.; Wu Y.T.; Lin S.C.; Kim D.W.; Kim D.; In vitro evaluation of novel inhibitors against the NS2B-NS3 protease of dengue fever virus type 4. Molecules 2013,18(12),15600-15612","journal-title":"Molecules"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jmgm.2014.06.008","volume":"52","author":"Mukhametov A.","year":"2014","unstructured":"Mukhametov A.; Newhouse E.I.; Aziz N.A.; Saito J.A.; Alam M.; Allosteric pocket of the dengue virus (serotype 2) NS2B\/NS3 protease: in silico ligand screening and molecular dynamics studies of inhibition. J Mol Graph Model 2014,52,103-113","journal-title":"J Mol Graph Model"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12985-015-0248-x","volume":"12","author":"Raut R.","year":"2015","unstructured":"Raut R.; Beesetti H.; Tyagi P.; Khanna I.; Jain S.K.; Jeankumar V.U.; Yogeeswari P.; Sriram D.; Swaminathan S.; A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture. Virol J 2015,12,16","journal-title":"Virol J"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejmech.2015.12.030","volume":"110","author":"Cabarcas-Montalvo M.","year":"2016","unstructured":"Cabarcas-Montalvo M.; Maldonado-Rojas W.; Montes-Grajales D.; Bertel-Sevilla A.; Wagner-D\u00f6bler I.; Sztajer H.; Reck M.; Flechas-Alarcon M.; Ocazionez R.; Olivero-Verbel J.; Discovery of antiviral molecules for dengue: in silico search and biological evaluation. Eur J Med Chem 2016,110,87-97","journal-title":"Eur J Med Chem"},{"key":"ref=208","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006411","volume":"13","author":"Brecher M.","year":"2017","unstructured":"Brecher M.; Li Z.; Liu B.; Zhang J.; Koetzner C.A.; Alifarag A.; Jones S.A.; Lin Q.; Kramer L.D.; Li H.; A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease. PLoS Pathog 2017,13(5)","journal-title":"PLoS Pathog"},{"key":"ref=209","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jmgm.2017.08.006","volume":"77","author":"Mirza S.B.","year":"2017","unstructured":"Mirza S.B.; Lee R.C.H.; Chu J.J.H.; Salmas R.E.; Mavromoustakos T.; Durdagi S.; Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies. J Mol Graph Model 2017,77,338-355","journal-title":"J Mol Graph Model"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10822-011-9418-0","volume":"25","author":"Knehans T.","year":"2011","unstructured":"Knehans T.; Sch\u00fcller A.; Doan D.N.; Nacro K.; Hill J.; G\u00fcntert P.; Madhusudhan M.S.; Weil T.; Vasudevan S.G.; Structure-guided fragment-based in silico drug design of dengue protease inhibitors. J Comput Aided Mol Des 2011,25(3),263-274","journal-title":"J Comput Aided Mol Des"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1016\/j.bmc.2011.05.015","volume":"19","author":"Steuer C.","year":"2011","unstructured":"Steuer C.; Gege C.; Fischl W.; Heinonen K.H.; Bartenschlager R.; Klein C.D.; Synthesis and biological evaluation of \u03b1-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture. Bioorg Med Chem 2011,19(13),4067-4074","journal-title":"Bioorg Med Chem"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/cbdd.12500","volume":"86","author":"Li L.","year":"2015","unstructured":"Li L.; Basavannacharya C.; Chan K.W.K.; Shang L.; Vasudevan S.G.; Yin Z.; Structure-guided discovery of a novel non-peptide inhibitor of Dengue virus NS2B-NS3 protease. Chem Biol Drug Des 2015,86(3),255-264","journal-title":"Chem Biol Drug Des"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/1873-3468.12232","volume":"590","author":"Chiang P.Y.","year":"2016","unstructured":"Chiang P.Y.; Wu H.N.; The role of surface basic amino acids of dengue virus NS3 helicase in viral RNA replication and enzyme activities. FEBS Lett 2016,590(14),2307-2320","journal-title":"FEBS Lett"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1128\/JVI.01788-07","volume":"82","author":"Luo D.","year":"2008","unstructured":"Luo D.; Xu T.; Hunke C.; Gr\u00fcber G.; Vasudevan S.G.; Lescar J.; Crystal structure of the NS3 protease-helicase from Dengue virus. J Virol 2008,82(1),173-183","journal-title":"J Virol"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"6686","DOI":"10.1128\/JVI.02215-05","volume":"80","author":"Sampath A.","year":"2006","unstructured":"Sampath A.; Xu T.; Chao A.; Luo D.; Lescar J.; Vasudevan S.G.; Structure-based mutational analysis of the NS3 helicase from Dengue virus. J Virol 2006,80(13),6686-6690","journal-title":"J Virol"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"12904","DOI":"10.1093\/nar\/gkx1127","volume":"45","author":"Swarbrick C.M.D.","year":"2017","unstructured":"Swarbrick C.M.D.; Basavannacharya C.; Chan K.W.K.; Chan S.A.; Singh D.; Wei N.; Phoo W.W.; Luo D.; Lescar J.; Vasudevan S.G.; NS3 helicase from Dengue virus specifically recognizes viral RNA sequence to ensure optimal replication. Nucleic Acids Res 2017,45(22),12904-12920","journal-title":"Nucleic Acids Res"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1038\/emboj.2008.232","volume":"27","author":"Luo D.","year":"2008","unstructured":"Luo D.; Xu T.; Watson R.P.; Scherer-Becker D.; Sampath A.; Jahnke W.; Yeong S.S.; Wang C.H.; Lim S.P.; Strongin A.; Vasudevan S.G.; Lescar J.; Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. EMBO J 2008,27(23),3209-3219","journal-title":"EMBO J"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"597","DOI":"10.18388\/abp.2002_3769","volume":"49","author":"Borowski P.","year":"2002","unstructured":"Borowski P.; Niebuhr A.; Schmitz H.; Hosmane R.S.; Bretner M.; Siwecka M.A.; Kulikowski T.; NTPase\/helicase of Flaviviridae: inhibitors and inhibition of the enzyme. Acta Biochim Pol 2002,49(3),597-614","journal-title":"Acta Biochim Pol"},{"key":"ref=219","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082504","volume":"8","author":"da Costa E.C.","year":"2013","unstructured":"da Costa E.C.; Amorim R.; da Silva F.C.; Rocha D.R.; Papa M.P.; de Arruda L.B.; Mohana-Borges R.; Ferreira V.F.; Tanuri A.; da Costa L.J.; Ferreira S.B.; Synthetic 1,4-pyran naphthoquinones are potent inhibitors of Dengue virus replication. PLoS One 2013,8(12)","journal-title":"PLoS One"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1021\/id5000458","volume":"1","author":"Sweeney N.L.","year":"2015","unstructured":"Sweeney N.L.; Hanson A.M.; Mukherjee S.; Ndjomou J.; Geiss B.J.; Steel J.J.; Frankowski K.J.; Li K.; Schoenen F.J.; Frick D.N.; Benzothiazole and pyrrolone Flavivirus inhibitors targeting the viral helicase. ACS Infect Dis 2015,1(3),140-148","journal-title":"ACS Infect Dis"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1107\/S2059798317003849","volume":"73","author":"Pan A.","year":"2017","unstructured":"Pan A.; Saw W.G.; Subramanian Manimekalai M.S.; Gr\u00fcber A.; Joon S.; Matsui T.; Weiss T.M.; Gr\u00fcber G.; Structural features of NS3 of Dengue virus serotypes 2 and 4 in solution and insight into RNA binding and the inhibitory role of quercetin. Acta Crystallogr D Struct Biol 2017,73(Pt 5),402-419","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1128\/AAC.02251-12","volume":"57","author":"Byrd C.M.","year":"2013","unstructured":"Byrd C.M.; Grosenbach D.W.; Berhanu A.; Dai D.; Jones K.F.; Cardwell K.B.; Schneider C.; Yang G.; Tyavanagimatt S.; Harver C.; Wineinger K.A.; Page J.; Stavale E.; Stone M.A.; Fuller K.P.; Lovejoy C.; Leeds J.M.; Hruby D.E.; Jordan R.; Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase. Antimicrob Agents Chemother 2013,57(4),1902-1912","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbrc.2014.09.113","volume":"453","author":"Basavannacharya C.","year":"2014","unstructured":"Basavannacharya C.; Vasudevan S.G.; Suramin inhibits helicase activity of NS3 protein of Dengue virus in a fluorescence-based high throughput assay format. Biochem Biophys Res Commun 2014,453(3),539-544","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/jac\/dks147","volume":"67","author":"Mastrangelo E.","year":"2012","unstructured":"Mastrangelo E.; Pezzullo M.; De Burghgraeve T.; Kaptein S.; Pastorino B.; Dallmeier K.; de Lamballerie X.; Neyts J.; Hanson A.M.; Frick D.N.; Bolognesi M.; Milani M.; Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemother 2012,67(8),1884-1894","journal-title":"J Antimicrob Chemother"},{"key":"ref=225","doi-asserted-by":"publisher","DOI":"10.3390\/v9040091","volume":"9","author":"El Sahili A.","year":"2017","unstructured":"El Sahili A.; Lescar J.; Dengue virus non-structural protein 5. Viruses 2017,9(4)","journal-title":"Viruses"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1093\/nar\/gkv1294","volume":"44","author":"Potisopon S.","year":"2016","unstructured":"Potisopon S.; Priet S.; Collet A.; Decroly E.; Canard B.; Selisko B.; The methyltransferase domain of dengue virus protein NS5 ensures efficient RNA synthesis initiation and elongation by the polymerase domain. Nucleic Acids Res 2016,44(6),2974","journal-title":"Nucleic Acids Res"},{"key":"ref=227","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005451","volume":"12","author":"Klema V.J.","year":"2016","unstructured":"Klema V.J.; Ye M.; Hindupur A.; Teramoto T.; Gottipati K.; Padmanabhan R.; Choi K.H.; Dengue Virus Nonstructural Protein 5 (NS5) Assembles into a Dimer with a Unique Methyltransferase and Polymerase Interface. PLoS Pathog 2016,12(2)","journal-title":"PLoS Pathog"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1099\/vir.0.062208-0","volume":"95","author":"Dong H.","year":"2014","unstructured":"Dong H.; Fink K.; Z\u00fcst R.; Lim S.P.; Qin C.F.; Shi P.Y.; Flavivirus RNA methylation. J Gen Virol 2014,95(Pt 4),763-778","journal-title":"J Gen Virol"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1128\/JVI.02704-06","volume":"81","author":"Zhou Y.","year":"2007","unstructured":"Zhou Y.; Ray D.; Zhao Y.; Dong H.; Ren S.; Li Z.; Guo Y.; Bernard K.A.; Shi P.Y.; Li H.; Structure and function of flavivirus NS5 methyltransferase. J Virol 2007,81(8),3891-3903","journal-title":"J Virol"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"32586","DOI":"10.1074\/jbc.M110.129197","volume":"285","author":"Dong H.","year":"2010","unstructured":"Dong H.; Liu L.; Zou G.; Zhao Y.; Li Z.; Lim S.P.; Shi P.Y.; Li H.; Structural and functional analyses of a conserved hydrophobic pocket of flavivirus methyltransferase. J Biol Chem 2010,285(42),32586-32595","journal-title":"J Biol Chem"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1074\/jbc.M110.179184","volume":"286","author":"Lim S.P.","year":"2011","unstructured":"Lim S.P.; Sonntag L.S.; Noble C.; Nilar S.H.; Ng R.H.; Zou G.; Monaghan P.; Chung K.Y.; Dong H.; Liu B.; Bodenreider C.; Lee G.; Ding M.; Chan W.L.; Wang G.; Jian Y.L.; Chao A.T.; Lescar J.; Yin Z.; Vedananda T.R.; Keller T.H.; Shi P.Y.; Small molecule inhibitors that selectively block dengue virus methyltransferase. J Biol Chem 2011,286(8),6233-6240","journal-title":"J Biol Chem"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jmb.2007.07.005","volume":"372","author":"Egloff M.P.","year":"2007","unstructured":"Egloff M.P.; Decroly E.; Malet H.; Selisko B.; Benarroch D.; Ferron F.; Canard B.; Structural and functional analysis of methylation and 5\u2032-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5. J Mol Biol 2007,372(3),723-736","journal-title":"J Mol Biol"},{"key":"ref=233","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025795","volume":"6","author":"Henderson B.R.","year":"2011","unstructured":"Henderson B.R.; Saeedi B.J.; Campagnola G.; Geiss B.J.; Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme. PLoS One 2011,6(10)","journal-title":"PLoS One"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.virol.2010.03.011","volume":"402","author":"Chung K.Y.","year":"2010","unstructured":"Chung K.Y.; Dong H.; Chao A.T.; Shi P.Y.; Lescar J.; Lim S.P.; Higher catalytic efficiency of N-7-methylation is responsible for processive N-7 and 2\u2032-O methyltransferase activity in dengue virus. Virology 2010,402(1),52-60","journal-title":"Virology"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.antiviral.2014.09.003","volume":"111","author":"Noble C.G.","year":"2014","unstructured":"Noble C.G.; Li S.H.; Dong H.; Chew S.H.; Shi P.Y.; Crystal structure of Dengue virus methyltransferase without S-adenosyl-L-methionine. Antiviral Res 2014,111,78-81","journal-title":"Antiviral Res"},{"key":"ref=236","first-page":"255","volume":"37","author":"Zweygarth E.","year":"1986","unstructured":"Zweygarth E.; Schillinger D.; Kaufmann W.; Rottcher D.;  evaluation of sinefungin for the treatment of trypanosoma (nannomonas) congolense infections in goats. tropical medicine and parasitology : official organ of deutsche tropenmedizinische gesellschaft and of deutsche gesellschaft fur technische zusammenarbeit, 1986,37(3),255-257"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/acsinfecdis.5b00070","volume":"1","author":"Brecher M.","year":"2015","unstructured":"Brecher M.; Chen H.; Li Z.; Banavali N.K.; Jones S.A.; Zhang J.; Kramer L.D.; Li H.; Identification and characterization of novel broad-spectrum inhibitors of the Flavivirus methyltransferase. ACS Infect Dis 2015,1(8),340-349","journal-title":"ACS Infect Dis"},{"key":"ref=239","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130062","volume":"10","author":"Brecher M.","year":"2015","unstructured":"Brecher M.; Chen H.; Liu B.; Banavali N.K.; Jones S.A.; Zhang J.; Li Z.; Kramer L.D.; Li H.; Novel broad spectrum inhibitors targeting the Flavivirus methyltransferase. PLoS One 2015,10(6)","journal-title":"PLoS One"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1021\/acs.jmedchem.5b00327","volume":"58","author":"Vernekar S.K.","year":"2015","unstructured":"Vernekar S.K.; Qiu L.; Zhang J.; Kankanala J.; Li H.; Geraghty R.J.; Wang Z.; 5\u2032-Silylated 3\u2032-1,2,3-triazolyl thymidine analogues as inhibitors of West Nile virus and Dengue virus. J Med Chem 2015,58(9),4016-4028","journal-title":"J Med Chem"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/prot.10465","volume":"52","author":"Verdonk M.L.","year":"2003","unstructured":"Verdonk M.L.; Cole J.C.; Hartshorn M.J.; Murray C.W.; Taylor R.D.; Improved protein-ligand docking using GOLD. Proteins 2003,52(4),609-623","journal-title":"Proteins"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"7795","DOI":"10.1016\/j.bmc.2007.08.049","volume":"15","author":"Luzhkov V.B.","year":"2007","unstructured":"Luzhkov V.B.; Selisko B.; Nordqvist A.; Peyrane F.; Decroly E.; Alvarez K.; Karlen A.; Canard B.; Qvist J.; Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2'O)-methyltrans-ferase. Bioorg Med Chem 2007,15(24),7795-7802","journal-title":"Bioorg Med Chem"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"Friesner R.A.","year":"2004","unstructured":"Friesner R.A.; Banks J.L.; Murphy R.B.; Halgren T.A.; Klicic J.J.; Mainz D.T.; Repasky M.P.; Knoll E.H.; Shelley M.; Perry J.K.; Shaw D.E.; Francis P.; Shenkin P.S.; Glide: a new approach for rapid, accurate docking and scoring. Method and assessment of docking accuracy. J Med Chem 2004,47(7),1739-1749","journal-title":"J Med Chem"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"Halgren T.A.","year":"2004","unstructured":"Halgren T.A.; Murphy R.B.; Friesner R.A.; Beard H.S.; Frye L.L.; Pollard W.T.; Banks J.L.; Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 2004,47(7),1750-1759","journal-title":"J Med Chem"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1021\/jm900776m","volume":"53","author":"Podvinec M.","year":"2010","unstructured":"Podvinec M.; Lim S.P.; Schmidt T.; Scarsi M.; Wen D.; Sonntag L.S.; Sanschagrin P.; Shenkin P.S.; Schwede T.; Novel inhibitors of dengue virus methyltransferase: discovery by in vitro-driven virtual screening on a desktop computer grid. J Med Chem 2010,53(4),1483-1495","journal-title":"J Med Chem"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.antiviral.2008.08.005","volume":"80","author":"Lim S.P.","year":"2008","unstructured":"Lim S.P.; Wen D.; Yap T.L.; Yan C.K.; Lescar J.; Vasudevan S.G.; A scintillation proximity assay for Dengue virus NS5 2\u2032-O-methyltransferase-kinetic and inhibition analyses. Antiviral Res 2008,80(3),360-369","journal-title":"Antiviral Res"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"35638","DOI":"10.1074\/jbc.M400460200","volume":"279","author":"Benarroch D.","year":"2004","unstructured":"Benarroch D.; Egloff M.P.; Mulard L.; Guerreiro C.; Romette J.L.; Canard B.; A structural basis for the inhibition of the NS5 dengue virus mRNA 2\u2032-O-methyltransferase domain by ribavirin 5\u2032-triphosphate. J Biol Chem 2004,279(34),35638-35643","journal-title":"J Biol Chem"},{"key":"ref=248","doi-asserted-by":"publisher","DOI":"10.4172\/1948-593X.S8-002","volume":"S8","author":"Fusco D.N.","year":"2014","unstructured":"Fusco D.N.; Chung R.T.; Review of current Dengue treatment and therapeutics in development. J Bioanal Biomed 2014,S8","journal-title":"J Bioanal Biomed"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0166-3542(90)90029-7","volume":"13","author":"Malinoski F.J.","year":"1990","unstructured":"Malinoski F.J.; Hasty S.E.; Ussery M.A.; Dalrymple J.M.; Prophylactic ribavirin treatment of dengue type 1 infection in Rhesus monkeys. Antiviral Res 1990,13(3),139-149","journal-title":"Antiviral Res"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1086\/511310","volume":"195","author":"Schul W.","year":"2007","unstructured":"Schul W.; Liu W.; Xu H.Y.; Flamand M.; Vasudevan S.G.; A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis 2007,195(5),665-674","journal-title":"J Infect Dis"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2010.11.002","volume":"89","author":"Chang J.","year":"2011","unstructured":"Chang J.; Schul W.; Butters T.D.; Yip A.; Liu B.; Goh A.; Lakshminarayana S.B.; Alonzi D.; Reinkensmeier G.; Pan X.; Qu X.; Weidner J.M.; Wang L.; Yu W.; Borune N.; Kinch M.A.; Rayahin J.E.; Moriarty R.; Xu X.; Shi P.Y.; Guo J.T.; Block T.M.; Combination of \u03b1-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo. Antiviral Res 2011,89(1),26-34","journal-title":"Antiviral Res"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"8730","DOI":"10.1128\/JVI.00384-12","volume":"86","author":"Stahla-Beek H.J.","year":"2012","unstructured":"Stahla-Beek H.J.; April D.G.; Saeedi B.J.; Hannah A.M.; Keenan S.M.; Geiss B.J.; Identification of a novel antiviral inhibitor of the Flavivirus guanylyltransferase enzyme. J Virol 2012,86(16),8730-8739","journal-title":"J Virol"},{"key":"ref=253","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130083","volume":"10","author":"Bullard K.M.","year":"2015","unstructured":"Bullard K.M.; Gullberg R.C.; Soltani E.; Steel J.J.; Geiss B.J.; Keenan S.M.; Murine efficacy and pharmacokinetic evaluation of the Flaviviral NS5 capping enzyme 2-thioxothiazolidin-4-one inhibitor BG-323. PLoS One 2015,10(6)","journal-title":"PLoS One"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris G.M.; Huey R.; Lindstrom W.; Sanner M.F.; Belew R.K.; Goodsell D.S.; Olson A.J.; AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009,30(16),2785-2791","journal-title":"J Comput Chem"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2009.03.001","volume":"83","author":"Milani M.","year":"2009","unstructured":"Milani M.; Mastrangelo E.; Bollati M.; Selisko B.; Decroly E.; Bouvet M.; Canard B.; Bolognesi M.; Flaviviral methyltransferase\/RNA interaction: structural basis for enzyme inhibition. Antiviral Res 2009,83(1),28-34","journal-title":"Antiviral Res"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","volume":"91","author":"Berendsen H.J.C.","year":"1995","unstructured":"Berendsen H.J.C.; van der Spoel D.; van Drunen R.; GROMACS: A message-passing parallel molecular dynamics implementation. Comput Phys Commun 1995,91(1),43-56","journal-title":"Comput Phys Commun"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ejmech.2016.10.007","volume":"125","author":"Benmansour F.","year":"2017","unstructured":"Benmansour F.; Trist I.; Coutard B.; Decroly E.; Querat G.; Brancale A.; Barral K.; Discovery of novel Dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design. Eur J Med Chem 2017,125,865-880","journal-title":"Eur J Med Chem"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2008.06.007","volume":"80","author":"Malet H.","year":"2008","unstructured":"Malet H.; Mass\u00e9 N.; Selisko B.; Romette J.L.; Alvarez K.; Guillemot J.C.; Tolou H.; Yap T.L.; Vasudevan S.; Lescar J.; Canard B.; The flavivirus polymerase as a target for drug discovery. Antiviral Res 2008,80(1),23-35","journal-title":"Antiviral Res"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-1-4614-0980-9_12","volume":"726","author":"Choi K.H.","year":"2012","unstructured":"Choi K.H.; Viral polymerases. Adv Exp Med Biol 2012,726,267-304","journal-title":"Adv Exp Med Biol"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1002\/j.1460-2075.1989.tb08565.x","volume":"8","author":"Poch O.","year":"1989","unstructured":"Poch O.; Sauvaget I.; Delarue M.; Tordo N.; Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J 1989,8(12),3867-3874","journal-title":"EMBO J"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"12943","DOI":"10.3390\/ijms160612943","volume":"16","author":"Wu J.","year":"2015","unstructured":"Wu J.; Liu W.; Gong P.; A structural overview of RNA-dependent RNA polymerases from the Flaviviridae family. Int J Mol Sci 2015,16(6),12943-12957","journal-title":"Int J Mol Sci"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-540-79086-0_3","author":"De Clercq E.","year":"2009","unstructured":"De Clercq E.; Neyts J.; Antiviral agents acting as DNA or RNA chain terminators. Handb Exp Pharmacol 2009(189),53-84","journal-title":"Handb Exp Pharmacol"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1128\/JVI.74.2.851-863.2000","volume":"74","author":"Luo G.","year":"2000","unstructured":"Luo G.; Hamatake R.K.; Mathis D.M.; Racela J.; Rigat K.L.; Lemm J.; Colonno R.J.; De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus. J Virol 2000,74(2),851-863","journal-title":"J Virol"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1093\/nar\/gkt1106","volume":"42","author":"Surana P.","year":"2014","unstructured":"Surana P.; Satchidanandam V.; Nair D.T.; RNA-dependent RNA polymerase of Japanese encephalitis virus binds the initiator nucleotide GTP to form a mechanistically important pre-initiation state. Nucleic Acids Res 2014,42(4),2758-2773","journal-title":"Nucleic Acids Res"},{"key":"ref=265","author":"Romette J.","year":"2005","unstructured":"Romette J.; Selisko B.; Egloff M.; Benarroch D.; Canard B.;  Active truncated form of the RNA polymerase of flavivirus united states patent us patent 20050048472, 2005","journal-title":"Active truncated form of the RNA polymerase of flavivirus united states patent us patent 20050048472,"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1128\/JVI.02283-06","volume":"81","author":"Yap T.L.","year":"2007","unstructured":"Yap T.L.; Xu T.; Chen Y.L.; Malet H.; Egloff M.P.; Canard B.; Vasudevan S.G.; Lescar J.; Crystal structure of the Dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution. J Virol 2007,81(9),4753-4765","journal-title":"J Virol"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1128\/AAC.01335-10","volume":"55","author":"Vernachio J.H.","year":"2011","unstructured":"Vernachio J.H.; Bleiman B.; Bryant K.D.; Chamberlain S.; Hunley D.; Hutchins J.; Ames B.; Gorovits E.; Ganguly B.; Hall A.; Kolykhalov A.; Liu Y.; Muhammad J.; Raja N.; Walters C.R.; Wang J.; Williams K.; Patti J.M.; Henson G.; Madela K.; Aljarah M.; Gilles A.; McGuigan C.; INX-08189, a phosphoramidate prodrug of 6-O-methyl-2\u2032-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties. Antimicrob Agents Chemother 2011,55(5),1843-1851","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"49164","DOI":"10.1074\/jbc.M305041200","volume":"278","author":"Migliaccio G.","year":"2003","unstructured":"Migliaccio G.; Tomassini J.E.; Carroll S.S.; Tomei L.; Altamura S.; Bhat B.; Bartholomew L.; Bosserman M.R.; Ceccacci A.; Colwell L.F.; Cortese R.; De Francesco R.; Eldrup A.B.; Getty K.L.; Hou X.S.; LaFemina R.L.; Ludmerer S.W.; MacCoss M.; McMasters D.R.; Stahlhut M.W.; Olsen D.B.; Hazuda D.J.; Flores O.A.; Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J Biol Chem 2003,278(49),49164-49170","journal-title":"J Biol Chem"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.antiviral.2015.07.010","volume":"122","author":"Chen Y.L.","year":"2015","unstructured":"Chen Y.L.; Yokokawa F.; Shi P.Y.; The search for nucleoside\/nucleotide analog inhibitors of Dengue virus. Antiviral Res 2015,122,12-19","journal-title":"Antiviral Res"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1128\/AAC.04779-14","volume":"59","author":"Yeo K.L.","year":"2015","unstructured":"Yeo K.L.; Chen Y.L.; Xu H.Y.; Dong H.; Wang Q.Y.; Yokokawa F.; Shi P.Y.; Synergistic suppression of Dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors. Antimicrob Agents Chemother 2015,59(4),2086-2093","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2015.01.002","volume":"116","author":"Lee J.C.","year":"2015","unstructured":"Lee J.C.; Tseng C.K.; Wu Y.H.; Kaushik-Basu N.; Lin C.K.; Chen W.C.; Wu H.N.; Characterization of the activity of 2\u2032-C-methylcytidine against dengue virus replication. Antiviral Res 2015,116,1-9","journal-title":"Antiviral Res"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/infdis\/jiw226","volume":"214","author":"Eyer L.","year":"2016","unstructured":"Eyer L.; Nencka R.; Huvarov\u00e1 I.; Palus M.; Joao Alves M.; Gould E.A.; De Clercq E.; R\u016f\u017eek D.; Nucleoside Inhibitors of Zika Virus. J Infect Dis 2016,214(5),707-711","journal-title":"J Infect Dis"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.antiviral.2016.12.021","volume":"140","author":"Potisopon S.","year":"2017","unstructured":"Potisopon S.; Ferron F.; Fattorini V.; Selisko B.; Canard B.; Substrate selectivity of Dengue and Zika virus NS5 polymerase towards 2\u2032-modified nucleotide analogues. Antiviral Res 2017,140,25-36","journal-title":"Antiviral Res"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1128\/AAC.01262-12","volume":"57","author":"Denning J.","year":"2013","unstructured":"Denning J.; Cornpropst M.; Flach S.D.; Berrey M.M.; Symonds W.T.; Pharmacokinetics, safety, and tolerability of GS-9851, a nucleotide analog polymerase inhibitor for hepatitis C virus, following single ascending doses in healthy subjects. Antimicrob Agents Chemother 2013,57(3),1201-1208","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"34337","DOI":"10.1074\/jbc.M110.161802","volume":"285","author":"Murakami E.","year":"2010","unstructured":"Murakami E.; Tolstykh T.; Bao H.; Niu C.; Steuer H.M.; Bao D.; Chang W.; Espiritu C.; Bansal S.; Lam A.M.; Otto M.J.; Sofia M.J.; Furman P.A.; Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977. J Biol Chem 2010,285(45),34337-34347","journal-title":"J Biol Chem"},{"key":"ref=276","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.13091","author":"Gan C.S.","year":"2017","unstructured":"Gan C.S.; Lim S.K.; Chee C.F.; Yusof R.; Heh C.H.; Sofosbuvir as treatment against dengue? Chem Biol Drug Des 2017","journal-title":"Chem Biol Drug Des"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"6345","DOI":"10.1038\/s41598-017-06612-2","volume":"7","author":"Xu H.T.","year":"2017","unstructured":"Xu H.T.; Colby-Germinario S.P.; Hassounah S.A.; Fogarty C.; Osman N.; Palanisamy N.; Han Y.; Oliveira M.; Quan Y.; Wainberg M.A.; Evaluation of Sofosbuvir (\u03b2-D-2\u2032-deoxy-2\u2032-\u03b1-fluoro-2\u2032-\u03b2-C-methyluridine) as an inhibitor of Dengue virus replication<sup\/>. Sci Rep 2017,7(1),6345","journal-title":"Sci Rep"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/infdis\/jis470","volume":"207","author":"Nguyen N.M.","year":"2013","unstructured":"Nguyen N.M.; Tran C.N.; Phung L.K.; Duong K.T.; Huynh, Hle.A.; Farrar, J.; Nguyen, Q.T.; Tran, H.T.; Nguyen, C.V.; Merson, L.; Hoang, L.T.; Hibberd, M.L.; Aw, P.P.; Wilm, A.; Nagarajan, N.; Nguyen, D.T.; Pham, M.P.; Nguyen, T.T.; Javanbakht, H.; Klumpp, K.; Hammond, J.; Petric, R.; Wolbers, M.; Nguyen, C.T.; Simmons, C.P. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 2013,207(9),1442-1450","journal-title":"J Infect Dis"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"20435","DOI":"10.1073\/pnas.0907010106","volume":"106","author":"Yin Z.","year":"2009","unstructured":"Yin Z.; Chen Y.L.; Schul W.; Wang Q.Y.; Gu F.; Duraiswamy J.; Kondreddi R.R.; Niyomrattanakit P.; Lakshminarayana S.B.; Goh A.; Xu H.Y.; Liu W.; Liu B.; Lim J.Y.; Ng C.Y.; Qing M.; Lim C.C.; Yip A.; Wang G.; Chan W.L.; Tan H.P.; Lin K.; Zhang B.; Zou G.; Bernard K.A.; Garrett C.; Beltz K.; Dong M.; Weaver M.; He H.; Pichota A.; Dartois V.; Keller T.H.; Shi P.Y.; An adenosine nucleoside inhibitor of Dengue virus. Proc Natl Acad Sci USA 2009,106(48),20435-20439","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1128\/AAC.00397-10","volume":"54","author":"Chen Y.L.","year":"2010","unstructured":"Chen Y.L.; Yin Z.; Lakshminarayana S.B.; Qing M.; Schul W.; Duraiswamy J.; Kondreddi R.R.; Goh A.; Xu H.Y.; Yip A.; Liu B.; Weaver M.; Dartois V.; Keller T.H.; Shi P.Y.; Inhibition of dengue virus by an ester prodrug of an adenosine analog. Antimicrob Agents Chemother 2010,54(8),3255-3261","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1021\/jm100593s","volume":"53","author":"Wu R.","year":"2010","unstructured":"Wu R.; Smidansky E.D.; Oh H.S.; Takhampunya R.; Padmanabhan R.; Cameron C.E.; Peterson B.R.; Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses. J Med Chem 2010,53(22),7958-7966","journal-title":"J Med Chem"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.antiviral.2017.03.012","volume":"142","author":"Eyer L.","year":"2017","unstructured":"Eyer L.; Zouharov\u00e1 D.; \u0160irmarov\u00e1 J.; Fojt\u00edkov\u00e1 M.; \u0160tef\u00e1nik M.; Haviernik J.; Nencka R.; de Clercq E.; R\u016f\u017eek D.; Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses. Antiviral Res 2017,142,63-67","journal-title":"Antiviral Res"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1128\/AAC.03368-14","volume":"58","author":"Julander J.G.","year":"2014","unstructured":"Julander J.G.; Bantia S.; Taubenheim B.R.; Minning D.M.; Kotian P.; Morrey J.D.; Smee D.F.; Sheridan W.P.; Babu Y.S.; BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model. Antimicrob Agents Chemother 2014,58(11),6607-6614","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.antiviral.2016.11.003","volume":"137","author":"Julander J.G.","year":"2017","unstructured":"Julander J.G.; Siddharthan V.; Evans J.; Taylor R.; Tolbert K.; Apuli C.; Stewart J.; Collins P.; Gebre M.; Neilson S.; Van Wettere A.; Lee Y.M.; Sheridan W.P.; Morrey J.D.; Babu Y.S.; Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model. Antiviral Res 2017,137,14-22","journal-title":"Antiviral Res"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jiph.2016.04.002","volume":"9","author":"Taylor R.","year":"2016","unstructured":"Taylor R.; Kotian P.; Warren T.; Panchal R.; Bavari S.; Julander J.; Dobo S.; Rose A.; El-Kattan Y.; Taubenheim B.; Babu Y.; Sheridan W.P.; BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease. J Infect Public Health 2016,9(3),220-226","journal-title":"J Infect Public Health"},{"key":"ref=286","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature13027","volume":"508","author":"Warren T.K.","year":"2014","unstructured":"Warren T.K.; Wells J.; Panchal R.G.; Stuthman K.S.; Garza N.L.; Van Tongeren S.A.; Dong L.; Retterer C.J.; Eaton B.P.; Pegoraro G.; Honnold S.; Bantia S.; Kotian P.; Chen X.; Taubenheim B.R.; Welch L.S.; Minning D.M.; Babu Y.S.; Sheridan W.P.; Bavari S.; Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature 2014,508(7496),402-405","journal-title":"Nature"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1016\/j.bmc.2012.08.021","volume":"20","author":"Tich\u00fd M.","year":"2012","unstructured":"Tich\u00fd M.; Pohl R.; Xu H.Y.; Chen Y.L.; Yokokawa F.; Shi P.Y.; Hocek M.; Synthesis and antiviral activity of 4,6-disubstituted pyrimido[4,5-b]indole ribonucleosides. Bioorg Med Chem 2012,20(20),6123-6133","journal-title":"Bioorg Med Chem"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1016\/j.bmc.2013.06.011","volume":"21","author":"Tich\u00fd M.","year":"2013","unstructured":"Tich\u00fd M.; Pohl R.; Tlou\u0161t\u2019ov\u00e1 E.; Weber J.; Bahador G.; Lee Y.J.; Hocek M.; Synthesis and biological activity of benzo-fused 7-deazaadenosine analogues. 5- and 6-substituted 4-amino- or 4-alkylpyrimido[4,5-b]indole ribonucleosides. Bioorg Med Chem 2013,21(17),5362-5372","journal-title":"Bioorg Med Chem"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejmech.2013.04.034","volume":"65","author":"Chatelain G.","year":"2013","unstructured":"Chatelain G.; Debing Y.; De Burghgraeve T.; Zmurko J.; Saudi M.; Rozenski J.; Neyts J.; Van Aerschot A.; In search of flavivirus inhibitors: evaluation of different tritylated nucleoside analogues. Eur J Med Chem 2013,65,249-255","journal-title":"Eur J Med Chem"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.antiviral.2013.01.011","volume":"98","author":"De Burghgraeve T.","year":"2013","unstructured":"De Burghgraeve T.; Selisko B.; Kaptein S.; Chatelain G.; Leyssen P.; Debing Y.; Jacobs M.; Van Aerschot A.; Canard B.; Neyts J.; 3\u2032,5'Di-O-trityluridine inhibits in vitro flavivirus replication. Antiviral Res 2013,98(2),242-247","journal-title":"Antiviral Res"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/open.201500216","volume":"5","author":"McGuigan C.","year":"2016","unstructured":"McGuigan C.; Serpi M.; Slusarczyk M.; Ferrari V.; Pertusati F.; Meneghesso S.; Derudas M.; Farleigh L.; Zanetta P.; Bugert J.; Anti-flavivirus activity of different tritylated pyrimidine and purine nucleoside analogues. Chem Open 2016,5(3),227-235","journal-title":"Chem Open"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejmech.2014.02.011","volume":"76","author":"Saudi M.","year":"2014","unstructured":"Saudi M.; Zmurko J.; Kaptein S.; Rozenski J.; Neyts J.; Van Aerschot A.; In search of Flavivirus inhibitors part 2: tritylated, diphenylmethylated and other alkylated nucleoside analogues. Eur J Med Chem 2014,76,98-109","journal-title":"Eur J Med Chem"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"7934","DOI":"10.1021\/jm901044z","volume":"52","author":"Yin Z.","year":"2009","unstructured":"Yin Z.; Chen Y.L.; Kondreddi R.R.; Chan W.L.; Wang G.; Ng R.H.; Lim J.Y.; Lee W.Y.; Jeyaraj D.A.; Niyomrattanakit P.; Wen D.; Chao A.; Glickman J.F.; Voshol H.; Mueller D.; Spanka C.; Dressler S.; Nilar S.; Vasudevan S.G.; Shi P.Y.; Keller T.H.; N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase. J Med Chem 2009,52(24),7934-7937","journal-title":"J Med Chem"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1128\/JVI.02451-09","volume":"84","author":"Niyomrattanakit P.","year":"2010","unstructured":"Niyomrattanakit P.; Chen Y.L.; Dong H.; Yin Z.; Qing M.; Glickman J.F.; Lin K.; Mueller D.; Voshol H.; Lim J.Y.; Nilar S.; Keller T.H.; Shi P.Y.; Inhibition of dengue virus polymerase by blocking of the RNA tunnel. J Virol 2010,84(11),5678-5686","journal-title":"J Virol"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1128\/JVI.00045-13","volume":"87","author":"Noble C.G.","year":"2013","unstructured":"Noble C.G.; Lim S.P.; Chen Y.L.; Liew C.W.; Yap L.; Lescar J.; Shi P.Y.; Conformational flexibility of the Dengue virus RNA-dependent RNA polymerase revealed by a complex with an inhibitor. J Virol 2013,87(9),5291-5295","journal-title":"J Virol"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"8541","DOI":"10.1074\/jbc.M115.710731","volume":"291","author":"Noble C.G.","year":"2016","unstructured":"Noble C.G.; Lim S.P.; Arora R.; Yokokawa F.; Nilar S.; Seh C.C.; Wright S.K.; Benson T.E.; Smith P.W.; Shi P.Y.; A conserved pocket in the Dengue virus polymerase identified through fragment-based screening. J Biol Chem 2016,291(16),8541-8548","journal-title":"J Biol Chem"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1021\/acs.jmedchem.6b00143","volume":"59","author":"Yokokawa F.","year":"2016","unstructured":"Yokokawa F.; Nilar S.; Noble C.G.; Lim S.P.; Rao R.; Tania S.; Wang G.; Lee G.; Hunziker J.; Karuna R.; Manjunatha U.; Shi P.Y.; Smith P.W.; Discovery of potent non-nucleoside inhibitors of Dengue viral RNA-dependent RNA polymerase from a fragment hit using structure-based drug design. J Med Chem 2016,59(8),3935-3952","journal-title":"J Med Chem"},{"key":"ref=298","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005737","volume":"12","author":"Lim S.P.","year":"2016","unstructured":"Lim S.P.; Noble C.G.; Seh C.C.; Soh T.S.; El Sahili A.; Chan G.K.; Lescar J.; Arora R.; Benson T.; Nilar S.; Manjunatha U.; Wan K.F.; Dong H.; Xie X.; Shi P.Y.; Yokokawa F.; Potent allosteric Dengue virus NS5 polymerase inhibitors: mechanism of action and resistance profiling. PLoS Pathog 2016,12(8)","journal-title":"PLoS Pathog"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.antiviral.2016.09.007","volume":"134","author":"Tarantino D.","year":"2016","unstructured":"Tarantino D.; Cannalire R.; Mastrangelo E.; Croci R.; Querat G.; Barreca M.L.; Bolognesi M.; Manfroni G.; Cecchetti V.; Milani M.; Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor. Antiviral Res 2016,134,226-235","journal-title":"Antiviral Res"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1042\/BJ20120150","volume":"443","author":"Wagstaff K.M.","year":"2012","unstructured":"Wagstaff K.M.; Sivakumaran H.; Heaton S.M.; Harrich D.; Jans D.A.; Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and Dengue virus. Biochem J 2012,443(3),851-856","journal-title":"Biochem J"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.antiviral.2013.06.002","volume":"99","author":"Tay M.Y.","year":"2013","unstructured":"Tay M.Y.; Fraser J.E.; Chan W.K.; Moreland N.J.; Rathore A.P.; Wang C.; Vasudevan S.G.; Jans D.A.; Nuclear localization of Dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin. Antiviral Res 2013,99(3),301-306","journal-title":"Antiviral Res"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/infdis\/jiu319","volume":"210","author":"Fraser J.E.","year":"2014","unstructured":"Fraser J.E.; Watanabe S.; Wang C.; Chan W.K.; Maher B.; Lopez-Denman A.; Hick C.; Wagstaff K.M.; Mackenzie J.M.; Sexton P.M.; Vasudevan S.G.; Jans D.A.; A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection. J Infect Dis 2014,210(11),1780-1791","journal-title":"J Infect Dis"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.1021\/acs.jmedchem.5b00108","volume":"58","author":"Vincetti P.","year":"2015","unstructured":"Vincetti P.; Caporuscio F.; Kaptein S.; Gioiello A.; Mancino V.; Suzuki Y.; Yamamoto N.; Crespan E.; Lossani A.; Maga G.; Rastelli G.; Castagnolo D.; Neyts J.; Leyssen P.; Costantino G.; Radi M.; Discovery of multitarget antivirals acting on both the Dengue virus NS5-NS3 interaction and the host Src\/Fyn kinases. J Med Chem 2015,58(12),4964-4975","journal-title":"J Med Chem"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1128\/AAC.04177-14","volume":"59","author":"Carocci M.","year":"2015","unstructured":"Carocci M.; Hinshaw S.M.; Rodgers M.A.; Villareal V.A.; Burri D.J.; Pilankatta R.; Maharaj N.P.; Gack M.U.; Stavale E.J.; Warfield K.L.; Yang P.L.; The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication. Antimicrob Agents Chemother 2015,59(1),85-95","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/1570162X14999160224103555","volume":"14","author":"Thenin-Houssier S.","year":"2016","unstructured":"Thenin-Houssier S.; Valente S.T.S.; HIV-1 capsid inhibitors as antiretroviral agents. Curr HIV Res 2016,14(3),270-282","journal-title":"Curr HIV Res"},{"key":"ref=306","unstructured":"w.h.o.neglected tropical diseases \u2212 summary,"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/168050","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/168050\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/168050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:13:08Z","timestamp":1608250388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/168050\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":306,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2020,9,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666181204155336","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}